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Abstract 
 
BACKGROUND: Changes in maternal insulin sensitivity throughout pregnancy 
may help supply nutrients to a growing fetus; however, the changes may concomitantly 
increase the mother and child’s risk for diabetes and chronic diseases.  Regular physical 
activity (PA) positively impacts precursors for diabetes, but the impact of PA throughout 
gestation is less studied. The purpose of this study was to examine the relationship between 
meeting PA recommendations and diabetes risk in pregnant women. METHODS: A total of 
23 pregnant women were recruited for participation. Venous blood samples, questionnaires, 
and anthropometric measurements (height, weight, and hip/waist circumferences) were 
ascertained during a single session. Participants also completed the MAQ physical activity 
recall questionnaire and wore a pedometer to record current PA. Daily step counts were 
recorded using a pedometer for two weeks following the blood draw.  Women were classified 
as meeting American College of Obstetrics and Gynecology (ACOG) recommendations 
(>450 MET·min/week) and/or ―active‖ (>5000 steps/day) based on their average steps/day. 
Blood samples were analyzed for levels of glucose (BGlu), glycosylated hemoglobin 
(HbA1c), total cholesterol (TCHOL), low density lipoprotein cholesterol (LDLC), high 
density lipoprotein cholesterol (HDLC) and triglycerides (TGs). Scatter plots were 
constructed for each biomarker versus gestational week to analyze differences in slopes and 
intercepts between two physical activity level groups. RESULTS: At the blood draw, 15 
(65.2%) women were meeting ACOG physical activity recommendations and 7 (36.8%) met 
an ―active‖ step count classification. Meeting activity recommendations was not significantly 
related to any biomarker after controlling for gestational age in univariate analysis, but an 
―active‖ daily step count approached significance in predicting HbA1c values (p=0.067). In 
scatter plot regression, there were significant differences in slopes for LDL (M0 – M1 = 
7.357, p=0.032) and total cholesterol (M0 – M1 = 7.568, p=0.043) based on meeting or not 
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meeting step count recommendations. Difference in intercepts from ACOG recommendations 
approached significance for HDL (-22.84, p=0.076). CONCLUSIONS: These results 
provide preliminary support that meeting or not meeting physical activity recommendations 
during pregnancy may be related to the progression of LDL, cholesterol, HDL, and HbA1c 
biomarkers for diabetes risk factors throughout gestation.
  
 
Chapter I 
 
Introduction 
 
The prevalence of obesity for children ages 6-11 years has increased from 6.5% in 
1980 to 19.6% in 2008[1]. Obesity during childhood is associated with poor health, including 
a high risk of obesity tracking into in adolescence and adulthood [2, 3]. Investigations 
indicate that the risk of high birth weight infants remaining overweight in childhood is more 
than that of non-overweight infants [4, 5]. Thus, offspring size is noted as an early indication 
of child weight status, and several perinatal factors such as parental body mass index (BMI), 
excess weight gain during pregnancy, and maternal gestational diabetes mellitus (GDM) are 
associated with risk for being born large for gestational age[6-12].   
The connection between GDM and offspring size is a significant health concern due 
to the increased risk for diabetes and other chronic diseases and conditions for both mother 
and child (e.g. CVD, cancer, gall bladder disease, etc) [13-16]. Specifically, offspring born to 
mothers with GDM not only suffer from increased risk of infant morbidity and obesity, but 
gestational exposure to glucose intolerance is also strongly linked to the future development 
of type II diabetes in the offspring [12, 17-19]. Reported rates of GDM in the United States 
range from 2% to 10% of pregnancies, and women who have had GDM also have a 35% to 
60% chance of developing diabetes in the 10-20 years after pregnancy [71]. Pregnancy is a 
physiological state that already compromises maternal insulin sensitivity as a normal manner 
of supplying adequate fuel sources to the growing fetus [20].Early pregnancy favors lipid 
deposition in the mother while inhibiting lipolysis as placenta hormones such as estrogen and 
progesterone aid fetal growth but partially block the action of the mother’s insulin [21]. As 
hormonal activity increases in the placenta, there is decreased activity of lipoprotein lipase 
(LPL) in the adipose and liver which leads to further decreases in insulin sensitivity as 
glucose is spared for the fetus [20]. Normal increases in blood volume and metabolites during 
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pregnancy impose a level of stress to the glucoregulatory system and the pancreas struggles 
to meet the 3- to 3.5-fold greater insulin needed in late pregnancy [22]. Mobilization of lipid 
stores in late pregnancy occurs as a shift from an anabolic to a catabolic state promotes the 
use of lipids as a maternal energy source while preserving glucose and amino acids for the 
fetus [20]. This fuel regulation process appears as a 3-fold increase in plasma triglycerol 
concentrations during the 3rd trimester and delayed postprandial clearance of fatty acids 
coupled with elevated plasma glucose levels [20, 21]. Thus, insulin action in late normal 
pregnancy is 50–70% lower than in non-pregnant women in response to expected increases in 
plasma glucose, plasma insulin, lipoproteins, and triglycerides mimicking a diabetic 
environment [20]. This normal progression of insulin resistance during pregnancy can 
become an issue of concern, however, as women are becoming pregnant at higher starting 
weights and gaining excess weight beyond healthy gestational weight gain recommendations 
which further promotes diabetic risk status [23-25].  
For ethnic women, compromised insulin sensitivity begins early in life.19 Latina 
women are more likely than their non-Latina peers to be diagnosed with GDM while 
concomitantly suffering a high prevalence of overweight and obesity [26, 27]. Women of 
child-bearing age in this ethnic population also have the highest fertility and birth rates [28, 
29]. The lifetime risk of developing diabetes is highest among Latinos, with a lifetime risk of 
50% for children born in the year 2000 [30].  Latino children, independent of body fat 
content, are also more insulin resistant than their Caucasian peers [31]. Furthermore, while 
examining hormonal changes during puberty, Goran et al [32] found a 32% reduction in 
insulin sensitivity consistent across sex, ethnicity, and obesity to demonstrate a natural 
hormonal change independent of demographic factors already inducing insulin resistance in 
this population. Therefore, regardless of other obesity or genetic metabolic risk factors, 
Latina women enter child-bearing years with a compromised state of insulin sensitivity [32]. 
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Insulin resistance is thus a critical determinant of diabetes-related pregnancy risk status 
among a diverse population of fertile women. Pregnant women, for instance, who are not 
clinically diagnosed with GDM but show serum indications of milder insulin resistance, may 
still be considered at a higher risk during pregnancy for diabetes-related complications and 
offspring outcomes [33-36]. Elevated LDL in the plasma lipid profile, large waist 
circumferences and anthropometric ratios, and chronically high hemoglobin A1c (HbA1c) 
percentages can reveal increased risk for insulin receptor desensitization and elevated blood 
glucose associated with type II diabetes [33-35]. In 2005-2008, based on fasted glucose or 
HbA1c levels, 35% of adults in the United States aged 20 years or older had prediabetes [71]. 
As a potential avenue for attenuating both biochemical and anthropometric risk status, 
participation in regular physical activity may help an individual reduce excess body fat and 
improve overall body composition [37]. Moreover, regular physical activity is known to 
positively impact precursors for diabetes [23, 38, 39]. Current literature indicates that 
maternal leisure-time physical activity (LTPA) before and during pregnancy is associated 
with reduced birth weight within the normal range and lower risk for being born large-for-
gestational-age [9-11]. Not only does physical activity confer maternal benefits during 
pregnancy, but also the results of earlier research studies have indicated that offspring of 
women who exercised vigorously throughout pregnancy continued to have significantly less 
body fat at five years of age compared to offspring of women who were sedentary during 
pregnancy [40]. Studies in the United States and abroad have found that any improvement in 
glycemic control can benefit individuals at risk for diabetes such that in general, every 
percentage drop in HbA1c blood test results can reduce the risk of microvascular 
complications by 40% [71]. Little is known, however, about how meeting or not meeting the 
current recommendations for physical activity during pregnancy impacts the progression of 
these risk factors for diabetes during gestation in non-GDM women.   
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Therefore, the purpose of this study is to examine how meeting or not meeting physical 
activity recommendations among a sample of pregnant women ages 19-35 affects the 
progression of diabetes risk status as indicated by both serum and anthropometric markers 
during gestation. It is hypothesized that women participating in more physical activity 
throughout pregnancy will have fewer indications exaggerated above the expected 
pregnancy-related diabetes risk than their less active peers. 
  
 
Chapter II 
 
Review of Literature 
 
Childhood obesity and future obesity/disease 
Numerous studies have been conducted to determine if a relationship exists between childhood 
obesity and future obesity in adulthood. Childhood obesity is often defined as BMI >95th percentile 
in age-for-BMI growth charts [2]. A review of previously published research highlights the 
association between obesity and central adiposity at any age with cardiovascular risk factors such as 
hypertension and insulin resistance[2]. As age increases, however, the persistent increase in 
overweight status is even more likely to track into adulthood with a greater percentage of obese 
adolescents at risk for adult obesity-related health consequences [3]. In a study examining risk ratios, 
the risk of overweight youth becoming overweight adults was reported to be at least two-fold higher 
than normal weight children [3]. Other investigations have focused on identifying the important 
factors to be considered as contributing to obesity in childhood. In a cohort study as part of the 
Quebec Longitudinal Study of Child Development [8] adjusted logistic regression analysis revealed 
that high birth weight, rate of infant weight gain between birth and five months, parental BMI, 
smoking during pregnancy, and low family income are all factors interacting with a child’s risk of 
obesity. The prevalence of childhood obesity is of particular concern given the adverse health effects, 
psychological morbidity, and cardiovascular disease risk persisting into adulthood [2]. As part of the 
Bogalusa Heart Study, a cross sectional autopsy-based study examining the factors associated with 
atherosclerosis and fibrous plaques in arteries discovered BMI to be a significant risk factor [15]. 
Similar associations have been reported concerning numerous other chronic diseases to confirm that 
the obesity-related risk factors for health consequences in adulthood also occur—and often begin—in 
childhood. 
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Table 1: Childhood Obesity and Future Obesity/Disease 
Articles  Problem/Question 
studied  
Participants  Procedures  Findings  
Reilly JJ, et al. 
Health 
consequences 
of obesity. 
Arch Dis 
Child. 2003. 
Evidence based 
summary of the 
consequences of 
childhood obesity 
in childhood and 
later adulthood 
38 studies 
identified 
association 
between 
obesity and 
central 
adiposity and 
cardiovascular 
risk factors in 
childhood: 
high BP, 
insulin 
resistance 
Examined associations 
between obesity and 
morbidity. If obesity >95th 
%ile, are there outcomes of 
morbidity, asthma, CHD risk 
factors, social/economic 
consequences long term. 
Measured persistence of 
obesity and type II diabetes 
co-morbidity 
Childhood obesity has 
adverse effects on 
health in childhood, 
psychological 
morbidity, and CHD 
risk. Persists into 
adulthood. 
Singh AS, et 
al. Tracking of 
childhood 
overweight 
into 
adulthood: A 
systematic 
review of the 
literature. 
Obes Rev. 
2008 
Examine 
persistence of 
childhood and 
adolescent 
overweight. 
Children <12 
yrs, 
adolescents 13-
18 yrs. 
Prospective 
and 
retrospective 
studies only.  
Measured increased risk in 
adulthood of obesity and 
health morbidity using BMI, 
skinfolds, or waist 
circumference to define body 
weight status. Compared 
different levels of body 
composition to the cutpoints 
of obesity from WHO 
guidelines. 
% of obese adolescents 
becoming 
overweight/obese 
higher than for 
children (24-90%). 
Dubois L, et 
al. Early 
determinants 
of overweight 
at 4.5 years in 
a population-
based 
longitudinal 
study. Int J 
Obes (lond). 
2006 
Determine early 
factors that exert 
most influence on 
overweight. 
1550/2103  
(74%) kids in 
Quebec Long 
Study of Child 
Development. 
Measured height and weight. 
"High BW" (>4kg) , 
WHZ>95% at 5mo, 
BMI>95% at 4.5 yrs in 
relation to rate of weight 
gain from birth to 5mo 
(quintiles), gender, 
gestational age, parity, 
breastfed, smoking during 
pregnancy, family income, 
parental height, parental 
overweight status (BMI 
>25), maternal 
age/education, and 
immigrant status. 
Factors important to 
consider for risk of 
overweight kids: high 
BW, rate of weight 
gain between birth and 
5months, parental 
BMI, pregnancy 
smoking, and current 
low income. 
Berenson GS, 
et al. 
Association 
between 
multiple 
cardiovascular 
risk factors 
and 
atherosclerosis 
in children 
and young 
adults: the 
bogalusa heart 
study. N Engl 
J Med. 1998 
Examine influence 
of multiple risk 
factors on extent of 
atherosclerosis in 
the aorta and 
coronary arteries in 
young people. 
Autopsies in 
Bogalusa Heart 
Study 204 
young people 
2-39 yrs old 
died from 
various causes. 
Studied smoking, LDL, 
blood pressure, BMI, 
cholesterol, and race in 
relation to antemortum risk 
factors.  
BMI related to 
atherosclerotic lesions 
in young people and 
appear in greater 
frequency. 
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Offspring size/birth weight and childhood obesity 
A substantial number of published reports have provided strong evidence of a positive 
relationship between child size at birth and childhood obesity.  Specifically, higher birth 
weight—or being born large for gestational age—has been associated with greater height, 
higher BMI, and higher fat free mass among youth boys and girls [41].  This correlation has 
been recorded as stable for over 48 birth years as birth weights greater than 4.0kg continue to 
be linked to higher risk of childhood obesity [5].  Several factors have been identified as risk 
factors involved in prenatal programming leading to higher birth weight infants.  The results 
of several studies document an association between higher birth weights and the presence of 
maternal obesity in early pregnancy, excess pregnancy weight gain, prenatal exposure to 
diabetes, low family income, and Latino ethnicity [6-8, 42]. The occurrence of overweight 
status defined at birth based on weight-for-height percentiles and weight-for-gestational-age 
growth charts is connected to a 2-fold increased risk of remaining overweight at four years of 
age compared to the risk among non-overweight infants [4].  Therefore, depending on levels 
of potentially modifiable risk factors existing in a pregnancy between mother and infant, the 
predicted probability of offspring being overweight at age three defined by sex-specific BMI 
z-scores can range from 6% to 29% at the low and high risk statuses respectively [43]. 
Cohort studies also reveal the significant impact that maternal height and weight status 
during pregnancy as well as six months postpartum has on the relationship to overweight 
children [6]. Thus, given the evidence-based analysis presented in the literature, it is 
important to recognize the pregnancy factors impacting offspring size because it correlates to 
future childhood obesity risk. 
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Table 2: Offspring Size/Birth Weight and Childhood Obesity 
Articles  Problem/Question 
studied  
Participants  Procedures  Findings  
Mei Z, et al. Does 
overweight in 
infancy persist 
through the 
preschool years? 
An analysis of 
CDC Pediatric 
Nutrition 
Surveillance 
System data. Soz 
Praventivmed. 
2003 
Determine whether 
overweight in low-
income US infants 
(0-11mo) and 
young children 
(12-35mo) persists 
though preschool 
years. 
CDC PedNSS 
database (born in 
1985-1990) 
4949,967 total 
children. Excluded 
those with missing 
data and those with 
WHZ below -4 and 
above +5. two 
groups: Weight for 
height %iles 
overweight and 
non-overweight. 
Stratified by sex, race, 
and birth weight groups. 
Used BW, 
anthropometric (ht, 
length, wt). Examined 
weight for height status 
>95th %ile overweight 
outcomes when 
presence of factors like 
overweight at birth, 
low-income, nutrition 
Overweight persists 
through the preschool 
years.  Risk of 
overweight infants 
remaining overweight 
at age 4 is over 2 times 
that of non-overweight 
infants. Relative risk 
increases with age. 
Those born into high 
WH%ile likely remain 
high during preschool. 
Olson CM, et al. 
Maternal weight 
gain during 
pregnancy and 
child weight at age 
3 years. Matern 
Child Health J. 
2008 
Determine the 
importance of 
pregnancy weight 
gain as a predictor 
of overweight 
(BMI >85th %ile) 
in offspring at age 
3 and if its 
influence varies by 
maternal BMI. 
208 mother-child 
pairs from earlier 
cohort study. All 
healthy, over 18 
yrs old, and 
singletons. Not 
low birth weight. 
Mothers 
categorized as low, 
normal, high, 
obese based on 
first trimester 
BMI. 
Maternal wt/ht recorded 
for first or second 
trimester, 6 mo 
postpartum, 1 and 2 yrs. 
The gestational weight 
gain (less, same, or 
more than 
recommended) related 
to child weight and 
length/ht at 1, 3, 5 yrs = 
BMI %ile based on 
CDC growth charts.  
Excess pregnancy 
weight gain is 
associated with 
increased risk of 
childhood overweight 
at age 3 and its impact 
is greater among high 
and obese BMI women 
than it is in normal 
BMI women. Higher 
maternal early 
pregnancy BMI 
increased likelihood of 
overweight offspring at 
3 yrs old. 
Whitaker RC. 
Predicting 
preschooler 
obesity at birth: the 
role of maternal 
obesity in early 
pregnancy. 
Pediatrics. 2004 
See if maternal 
obesity is related 
to toddler obesity 
at 2-4 yrs. 
8,494 WIC kids 
aged 2-4 yrs. 
Measured height and 
weight in 1st trimester 
from WIC records: 
maternal BMI of 30+ 
classified as BMI >= 
95th %. Also used birth 
certificate data: BW, 
birth year, gender, 
maternal age, race, 
education, marital 
status, parity, weight 
gain, and smoking. 
Maternal obesity in 
early pregnancy is a 
risk factor for child 
obesity among low-
income families. 
Relative risks are even 
stronger for moms w/ 
BMI 40+. Other traits 
associated with more 
obesity in childhood - 
male, null parity, 
Hispanic, and smoking.  
Dubois L, et al. 
Early determinants 
of overweight at 
4.5 years in a 
population-based 
longitudinal study. 
Int J Obes (lond). 
2006 
Determine early 
factors that exert 
most influence on 
overweight. 
1550/2103  (74%) 
kids in Quebec 
Long Study of 
Child 
Development. 
Measured height and 
weight. "High BW" 
(>4kg) , WHZ>95% at 
5mo, BMI>95% at 4.5 
yrs in relation to rate of 
weight gain from birth 
to 5mo (quintiles), 
gender, gestational age, 
parity, breastfed, 
smoking during 
pregnancy, family 
income, parental height, 
parental overweight 
status (BMI >25), 
maternal age/education, 
and immigrant status. 
Factors important to 
consider for risk of 
overweight kids: high 
BW, rate of weight 
gain between birth and 
5months, parental BMI, 
pregnancy smoking, 
and current low 
income. 
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Rugholm S, et al. 
Stability of the 
association 
between birth 
weight and 
childhood 
overweight during 
the development of 
the obesity 
epidemic. Obes 
Res. 2005 
Assess how 
changes in birth 
weight distribution 
or changes in 
association of birth 
weight with later 
risk of childhood 
overweight status 
have contributed to 
obesity epidemic. 
Danish population, 
infants with birth 
weights <5.5kg. 
Measured birth weight 
and annual measures of 
height and weight from 
school records. 
Calculated relative risk 
of being overweight for 
age, sex, and time 
period. Calculated 
relative risk for being 
overweight and 
compared RR in each of 
the three time intervals 
during the epidemic.  
Higher risk in children 
born >4.0kg. 
Association stable 
between birth weight 
and overweight over 48 
birth years. 
Development of 
obesity epidemic is a 
result neither of secular 
changes in birth weight 
distribution nor secular 
changes in association 
between birth weight 
and later risk of 
overweight. 
Huang JS, Lee TA, 
Lu MC 2006. 
Prenatal 
programming of 
childhood 
overweight and 
obesity 
Review the 
scientific evidence 
for prenatal 
programming of 
childhood 
overweight and 
obesity, and 
discuss its 
implications for 
maternal and child 
health research, 
practice, and 
policy 
Literature on 
PubMed and 
MDConsult 
published between 
Jan 1975 and Dec 
2005. 
Lit searches on PubMed 
and MDConsult. Odds 
ratios with confidence 
intervals were 
calculated using CDC's 
Epi Info software 
program. Childhood 
overweight or obesity 
measured by BMI for 
children ages 5 to 21 in 
relation to exposures of 
maternal diabetes, 
malnutrition, cigarette 
smoking. 
Fair to good evidence in 
support of prenatal 
programming: positive 
associations between 
prenatal exposure to 
diabetes, malnutrition, 
and smoking to obesity. 
Suggests that prenatal 
period is critical for 
intervention. 
Chomtho et al 
2008. Associations 
between birth 
weight and later 
body composition: 
evidence from the 
4-component 
model 
Investigate 
associations 
between birth 
weight and later fat 
mass, fat free 
mass, and fat 
distribution. 
Healthy term born 
children and 
adolescents (4-20 
yrs) in London, all 
singletons. 
Birth weight and 
gestational age data 
from parental recall and 
baby book record. Used 
4C model (fat, water, 
protein, mineral) 
densities to measure 
FM, body volume (L), 
total body water (L), 
and body bone mineral 
content (kg).  
Higher birth weight 
associated with greater 
height in both sexes and 
higher BMI in boys. 
Higher birth weight 
with higher FFM in 
boys but not girls. DXA 
data showed weak 
positive association 
between birth weight 
and fat mass not 
apparent in 4C model. 
Evidence for 
programming of later 
fat mass or central fat 
by birth weight is not 
strong. 
Gillman et al 2008. 
Developmental 
origins of 
childhood 
overweight: 
potential public 
health impact 
Probability of 
overweight at age 
3 yrs for different 
combinations of 
four modifiable 
risk factors 
occurring 
prenatally and 
during the first 
year of life. 
1,110 mother-child 
pairs in Project 
Viva. Gestational 
age <22 weeks at 
initial clinic visit 
and all singletons. 
Measured child 
overweight (BMI for 
age and sex >95th %ile) 
at age 3: weight, length, 
age and sex specific 
BMI zscores in relation 
to factors like maternal 
smoking during 
pregnancy, gestational 
weight gain, 
breastfeeding duration, 
infant sleep duration.  
Predicted probability of 
overweight in childhood 
varied from 6-29% 
depending on levels of 
four potentially 
modifiable risk factors. 
Implies that appropriate 
interventions to modify 
these factors may have 
impact on prevention. 
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Maternal diabetes and offspring size/birth weight 
One of the major contributors that has been reported to significantly influence 
overweight infants and toddlers is the exposure to maternal diabetes.  Several cohort and 
longitudinal studies have documented the growth of children from pregnancies with 
gestational diabetes mellitus (GDM) and/or elevated maternal blood glucose levels.  While 
maternal obesity in the third trimester has been found to be associated with increased infant 
growth late in gestation [12], exposure to a diabetic perinatal environment also predicts the 
risk for metabolic syndrome and being born large-for-gestational-age [17].  Specifically, one 
cohort of children born large-for-gestational-age compared to those born appropriate-for-
gestational-age showed a 50% increased risk for developing metabolic syndrome in 
childhood if they were offspring of diabetic mothers [17]. Even among women who do not 
meet the diabetes diagnosis criteria set by the World Health Organization but still show the 
highest levels of fasting glucose compared to peers have been reported to be ten times more 
likely to give birth to newborns suffering from hyperinsulinemia  [36].  Infants exposed to 
diabetic perinatal environments are thus burdened with increasing body size and adiposity as 
they age and are noted to be heavier with larger circumference and skinfolds measurements 
[18]. Unfortunately, women without GDM in a retrospective cohort study who displayed 
more than one abnormal glucose value in several oral glucose tolerance tests had twofold 
greater risk of diabetes with similar high risk of offspring macrosomnia to a woman clinically 
diagnosed with GDM [33].  A review of  the literature highlights that maternal glucose levels 
not only adversely influence insulin sensitivity of an infant and being born large-for-
gestational-age, but also negatively impact the mother’s own risk for developing diabetes 
during and post-pregnancy[12, 33, 36]. Perinatal exposure to elevated glucose levels even to 
modest degrees has the potential to mimic health consequences similar to clinical diabetes 
[33, 36].  Thus, identifying maternal glycemia below criteria for diagnosis highlights a route 
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of intervention by revealing women with impaired beta-cell function and impaired glucose 
tolerance as pre-pregnancy predictors of fetal growth patterns [18, 36].  The compromised 
insulin sensitivity in maternal diabetes is also correlated to higher maternal adiposity and/or 
obesity of BMI >30 [12].  Overall, the association of maternal diabetes and resulting 
offspring size is documented in the literature and the investigations have utilized multiple 
avenues of analysis and investigation to reach this consensus.   
Table 3: Maternal Diabetes and Offspring Size/Birth Weight 
Articles Problem/Question 
studied  
Participants Procedures Findings  
Schaefer-Graf 
UM, et al. Birth 
weight and 
parental BMI 
predict 
overweight in 
children from 
mothers with 
gestational 
diabetes. 
Diabetes Care. 
2005 
Investigate the 
growth of children 
from pregnancies 
with GDM and its 
association with 
antenatal maternal, 
fetal, and recent 
anthropometric 
parameters of 
mother and father. 
Caucasian women 
with GDM (324) 
from Diabetes 
Prenatal Care 
Clinic of the 
Department of 
Obstetrics in 
Berlin. All 
singletons. 
 Measured birth weight 
status, GDM, maternal 
BMI before pregnancy, 
maternal glycemic 
values in addition to 
fetal macrosomnia 
(abdominal 
circumference >90th 
%ile), birth length, 
father BMI, weight and 
height of both parents.  
Increased BMI 
compared to German 
population in children 
of mothers with GDM. 
Predictors of child's 
BMI were BMI at birth 
(fetal abdominal 
circumference), current 
BMI of mother and 
father.  Infants of GDM 
had 67% rate of 
childhood overweight 
with obese parents 
compared to 19% when 
parents BMI <30. 
Suggests relationship 
between overweight at 
birth and overweight in 
childhood. Low BW not 
associated with 
childhood obesity. 
Postprandial glucose in 
3rd trimester was a 
predictor. Maternal 
obesity associated with 
increased growth in late 
gestation. 
Boney CM, et 
al. Metabolic 
syndrome in 
childhood: 
association with 
birth weight, 
maternal 
obesity, and 
gestational 
diabetes 
mellitus. 
Pediatrics. 2005 
Determine the 
effects of large-
for-gestational-age 
birth status and 
maternal GDM on 
the development of 
metabolic 
syndrome. 
Children ages 6, 
7, 9, 11 who were 
LGA or AGA of 
mothers with or 
without GDM. 
Divided into 4 
groups: LGA of 
control mothers, 
LGA of mothers 
GDM, AGA of 
control mothers, 
AGA of mothers 
GDM. 
Measured LGA status 
and maternal GDM in 
relation to major 
components of 
metabolic syndrome: 
obesity (BMI >85th 
%ile), hypertension 
(diastolic or systolic BP 
>95th %ile), glucose 
tolerance (fasting 
glucose >110 mg/dL), 
and dyslipidemia 
(triglyceride >95th %ile 
and HDL <5th %ile).  
Exposure of children to 
maternal obesity was 
strong predictor of risk 
for metabolic syndrome 
and LGA status. 
Obesity in children is a 
significant risk factor 
for development of 
insulin resistance and 
correlated by degree of 
severity. LGA offspring 
of diabetic mothers are 
at risk for metabolic 
syndrome (50% at risk, 
15% met risk criteria). 
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Vohr BR, et al. 
Effects of 
maternal 
gestational 
diabetes on 
offspring 
adiposity at 4-7 
years of age. 
Diabetes Care. 
1999 
Assess long-term 
effects of maternal 
prenatal factors on 
adiposity of 
offspring. 
Four groups of 
children: LGA 
from mothers of 
GDM, AGA from 
GDM, LGA 
control, AGA 
control. 
Measured adiposity of 
offspring 4 to 7 yrs to 
data of GDM, adiposity, 
and weight gain during 
pregnancy. Used 
repeated measures of 
variance models to 
detect different patterns 
of longitudinal change 
in groups. 
LGA from GDM show 
increasing body size 
and adiposity with age, 
and maternal GDM and 
pre-pregnancy adiposity 
are predictors of fetal 
growth patterns. 
Carr DB, et al. 
Modestly 
elevated glucose 
levels during 
pregnancy are 
associated with 
a higher risk for 
future diabetes 
among women 
without 
gestational 
diabetes 
mellitus. 
Diabetes Care. 
2008 
Determine whether 
1-hr oral glucose 
challenge test 
(OGCT) or 3-hr 
oral glucose 
tolerance test 
(OGTT) results 
below GDM 
criteria are 
associated with 
developing 
diabetes 
Women without 
GDM who had 
pregnancy OGGT 
or OGTT, 1st 
pregnancies only.  
Collected normal, one 
abnormal, or two+ 
abnormal values of 
OGTT during tests and 
classified as having 
type II diabetes after 
pregnancy fasting 
glucose >7.0 mmol/L. 
Incidence rates 
calculated. 
Women with high 
OGCT had 1.7-2 fold 
higher risk of 
developing diabetes 
compared to those with 
lower glucose values. 
More than one 
abnormal OGTT had 
twofold greater diabetes 
risk. Risk not attenuated 
by adjustment for age or 
preterm delivery. One 
abnormal OGTT has 
higher risk of 
macrosomia similar to 
GDM even with modest 
values. 
Hampton, T. 
Study finds 
newborn 
outcomes 
affected by 
blood glucose 
levels during 
pregnancy. 
Journal of the 
American 
Medical 
Association. 
2007 
Examine the effect 
of blood glucose 
levels in pregnant 
women that are 
elevated but still 
within the normal 
range on risks for 
diabetes among 
newborns. 
Non-diabetic 
pregnant women 
at 28 weeks 
gestation. 
Measured glucose 
tolerance during third 
trimester of pregnancy: 
fasting glucose test and 
oral glucose tolerance 
test (1 and 2 hrs after 
75g glucose) and also 
adverse newborn 
outcomes: 
hyperinsulinemia, 
hypoglycemia, 
preeclampsia, 
macrosomnia.  
There are associations 
between blood glucose 
levels and adverse 
offspring outcomes in 
pregnant women whose 
levels are not high 
enough to be called 
diabetes. 
 
Obesity and diabetes in Latina women 
Latina women are more likely than their non-Latina peers to be diagnosed with GDM 
while simultaneously suffering a higher prevalence of overweight and obesity [1, 27].Women 
of child-bearing age in this ethnic population also have the highest fertility and birth rates 
according to national U.S. Census data [28].  For Latina women in particular, compromised 
insulin sensitivity begins early in life [44]. In fact, the lifetime risk of developing diabetes is 
highest among Latinos, with a lifetime risk of 50% for children born in the year 2000 [13].  
Females in this population are shown to be at higher risk at all ages in conjunction with 
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reduced life expectancy among all individuals diagnosed with diabetes [44].  In a longitudinal 
study among Latina women with clinically diagnosed GDM but not diabetes 4-16 weeks 
postpartum, BMI >29 increased their risk of meeting World Health Organization criteria for 
impaired glucose tolerance and 80% increased risk for developing diabetes [19]. Among a 
multiethnic cohort of obese children and adolescents, it was discovered that the effects of 
obesity on the deterioration of glucose tolerance most likely resulted from metabolic obesity-
related complications such as up regulation of beta-cell function due to hyperinsulinemia 
and/or chronic insulin resistance [13]. The evidence for Latina women being at higher 
lifetime risk of developing diabetes with paralleled health complications of higher obesity 
prevalence is compelling and disturbing.  
Table 4: Obesity and Diabetes in Latina Women 
Articles 
Problem/Question 
Studied Participants Procedures Findings 
Kjos SL, et al. 
Predicting 
future diabetes 
in Latino 
women with 
gestational 
diabetes. 
Utility of early 
postpartum 
glucose 
tolerance 
testing. 
Diabetes. 1995 
Test routine clinical 
parameters for 
ability to 
discriminate high 
and low risk of non-
insulin-dependent 
diabetes mellitus 
(NIDDM) within 5-
7 yrs of pregnancies 
complicated by 
GDM. 
Latina women 
with GDM but 
not diabetes 4-16 
weeks after 
delivery, fasting 
glucose >7.8 
mmol/l before 
discharge advised 
to return for 75g 
OGTT within 7.5 
years. 
Conducted 10-12hr 
overnight fast, 
measured fasting and 
post challenge 
glycemia, and 
recorded weight 
change since delivery.  
Glucose tolerance testing 
1-4 months after delivery 
provides useful info 
about risk of NIDDM in 
Latina women. All 
antepartum and 
postpartum glycemic 
variables were associated 
with NIDDM such as 
BMI >29. Postpartum 
glucose tolerance 
superior for defining risk 
of NIDDM after GDM 
pregnancies. 
Narayan KMV, 
et al. Lifetime 
risk for 
diabetes 
mellitus in the 
united states. 
JAMA. 2003 
Estimate an 
individual's average 
lifetime risk of 
developing diabetes. 
Data from 
National Health 
Interview Survey, 
US Census 
Bureau, and study 
on diabetes 
cause-of-death 
for mortality rates 
in 
diabetic/nondiabe
tic populations. 
Collected residual 
lifetime risk of 
diabetes (birth to 80 
yrs), duration of life 
with diabetes, and 
quality-adjusted life-
years lost from 
diabetes. Reported 
incidence rates, 
prevalence, relative 
risk ratio, probability 
of disease occurrence 
along with age, sex, 
race recorded. 
Latina women at high 
lifetime risk for 
developing diabetes. 
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Sinha R, et al. 
Prevalence of 
impaired 
glucose 
tolerance 
among children 
and adolescents 
with marked 
obesity. N Engl 
J Med. 2002 
Report the 
prevalence of 
impaired glucose 
tolerance in a 
multiethnic cohort 
of obese children 
and adolescents. 
55 children and 
112 adolescents 
from Yale 
Pediatric Obesity 
Clinic.  
Tested for impaired 
glucose tolerance 
defined by ADA 
guidelines. Assessed 
beta cell function 
using insulinogenic 
index calculated as 
ratio of increment in 
plasma insulin level to 
plasma glucose level 
after 30 min glucose 
ingestion. Insulin 
resistance determined 
by homeostatic model 
assessment. 
High prevalence of 
impaired glucose in 
multiethnic cohort of 
obese children and 
adolescents. Risk factors 
included insulin 
resistance and 
hyperinsulinemia. Effects 
of obesity on 
deterioration of glucose 
tolerance most likely 
mediated by metabolic 
complications like 
insulin resistance and 
hyperinsulinemia. 
Upregulation of beta-cell 
function caused by 
severe chronic insulin 
resistance. 
 
Insulin sensitivity and Latina women 
Latino children, independent of body fat content, have been shown to be more insulin 
resistant than their Caucasian peers [31]. Furthermore, while examining hormonal changes 
during puberty, Goran et al [32]found a 32% reduction in insulin sensitivity consistent across 
sex, ethnicity, and obesity subgroups independent of changes in body fat, visceral fat, and 
testosterone. This decrease in insulin sensitivity is a baseline occurrence across multiethnic 
adolescents further exasperating the already compensated status among Latino children with 
limited rebound capability [30].  In a study of factors surrounding the acute insulin response 
and disposition index among multiethnic children, Latino children were reported to 
compensate for insulin insensitivity at a similar degree to their African American peers but 
with a higher second-phase insulin secretion as opposed to using hepatic insulin extraction to 
spare the need for insulin secretion [30].  This insight into the mechanism among Latino 
children reveals critical beta-cell exhaustion beginning post-puberty which results in a rapid 
rise in glucose over time [45]. Important factors such as lower beta-cell function, lower acute 
insulin responses, and increasing visceral fat appear to be strong contributors to persistent 
pre-diabetes status among Latino children at risk for type II diabetes development [30, 45]. 
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The association between Latino heritage and reductions in insulin sensitivity becomes 
especially alarming when analyzing the prevalence of GDM increasing in Latina women 
from 2.8% to 5.1% between 1994 and 2002 as the proportion of pregnancies from minority 
women simultaneously increased within the same time period [27].  These statistics and 
relationships have been documented independent of changes in body fat.  Therefore, 
regardless of other obesity or genetic metabolic risk factors, Latina women enter child-
bearing years after puberty with a compromised state of insulin sensitivity [31]. 
Table 5: Insulin Sensitivity and Latina Women 
Articles Problem/Question 
Studied 
Participants Procedures Findings 
Dabela D, et al. 
Increasing 
prevalence of 
gestational 
diabetes mellitus 
over time and by 
birth cohort: 
Kaiser 
Permanente of 
Colorado GDM 
screening 
program. 
Diabetes Care. 
2005 
Examine temporal 
trends in GDM 
among diverse 
ethnic groups. 
Members of 
Kaiser 
Permanente of 
Colorado 
health plan 
who delivered 
singletons 
between 1994 
and 2002. 
Standard screening 
protocol and GDM 
diagnosed when two or 
more glucose values 
from OGTT met or 
exceeded criteria for 
positive test. 96% of all 
eligible women screened 
between 2001 and 2002 
and annual prevalence of 
GDM noted. 
Prevalence of 
GDM doubled 
between 1994 and 
2002 in  various 
ethnicities 
(Latinos).              
Goran MI, et al. 
Persistence of 
pre-diabetes in 
overweight and 
obese Hispanic 
children: 
association with 
progressive 
insulin 
resistance, poor 
beta-cell 
function, and 
increasing 
visceral fat. 
Diabetes. 2008 
Examine changes 
in risk factors 
among overweight 
and obese Hispanic 
children at high 
risk for developing 
type II diabetes. 
128 
overweight/obe
se Hispanic 
children with 
family history 
of type II 
diabetes from 
Los Angeles 
clinics. 
Evaluated for 4 yrs with 
oral glucose tolerance 
tests and ADA criteria to 
define diabetes and pre-
diabetes with repeated 
measures at 1,2,4 years. 
Measured insulin 
sensitivity, acute insulin 
response to glucose, and 
beta-cell function in 
addition to total body fat 
DEXA and intra-
abdominal and 
subcutaneous abdominal 
adipose tissue by MRI. 
In Hispanic 
children at risk for 
type II diabetes, 
those with 
persistent pre-
diabetes have 
lower beta cell 
function, due to 
lower AIR, and 
increasing visceral 
fat over time 
(prevalence over 3 
yrs = 13%). 
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Goran MI, et al. 
Insulin 
resistance and 
the associated 
compensatory 
response in 
Caucasian, 
African 
American, and 
Hispanic 
children. 
Diabetes Care. 
2002 
Compare insulin 
resistance relative 
to body fat and 
compensatory 
responses. 
57 healthy 
children (14 
white, 15 
African 
American, 28 
Hispanic) in 
Los Angeles. 
Measured insulin 
sensitivity, acute insulin 
response, disposition 
index (product of insulin 
sensitivity and acute 
insulin response), 
glucose effectiveness 
using fasting blood 
samples before FSIGTT: 
glucose, insulin, c-
peptide, free fatty acids. 
Pre-hepatic insulin 
secretion rates examined. 
Hispanic children 
more insulin 
resistant than 
Caucasian 
independent of 
adiposity. African 
Americans 
compensate with 
higher acute 
insulin response to 
glucose due to 
hepatic insulin 
extraction sparing 
the need to 
increase insulin 
secretion while 
Hispanic children 
compensate with 
greater insulin 
secretion. Hispanic 
compensated to the 
same degree of 
insulin resistance 
with a higher 
second-phase 
insulin secretion. 
Goran MI, et al. 
Longitudinal 
study on 
pubertal insulin 
resistance. 
Diabetes. 2005 
Examine pubertal 
stages in insulin 
secretion with 
changes in body 
fat and pubertal 
reduction in insulin 
sensitivity. 
60 children (33 
male, 27 
female, 32 
Caucasian, 28 
African 
American) 
tanner stage 1. 
Measured acute insulin 
response (AIR) and 
disposition index (DI). 
Recorded age, sex, 
ethnicity, fat mass from 
DEXA, visceral fat, and 
fasting blood hormones. 
AIR and DI using 
frequently sampled 
intravenous glucose 
tolerance test (FSIGTT) 
after overnight fast. 
Created index of beta-
cell function. Studied 
association between 
changes in SI and change 
in body fat 
mass/hormones.  
SI reduction 
association with 
tanner I to III or IV 
and 
disproportionately 
low increase in 
AIR to suggest a 
conservation in 
beta-cell function 
or inadequate beta-
cell response not 
associated with 
body fat changes.  
Xiang AH, et al. 
Coordinate 
changes in 
plasma glucose 
and pancreatic 
beta-cell 
function in 
Latino women at 
high risk for 
type 2 diabetes. 
Diabetes. 2006 
Examine 
relationship among 
glucose levels, 
beta-cell function, 
and insulin 
resistance in 
women at high risk 
for type II 
diabetes. 
150 islet cell 
antibody-
negative 
women after 
GDM, Latino 
managing 
GDM in Los 
Angeles. 
Gestational age 
28-34 weeks, 
no insulin 
therapy, and 
fasting glucose 
<130 mg/dl 
during 
pregnancy. 
Metabolic testing in 3rd 
trimester, 75g OGTT 6 
months postpartum and 
every 15 months after. 
Measured AIR and 
disposition index (SI x 
AIR) for acute pancreatic 
beta-cell compensation 
for insulin resistance. 
Diabetes diagnosed from 
ADA criteria. MINMOD 
program to measure 
fractional glucose 
disappearance due to 
increase in insulin above 
basal level. 
Latina women with 
recent GDM had 
marked insulin 
resistance that 
changed very little 
during 5 year 
follow-up while 
beta-cell function 
declined. Rapid 
rise in glucose for 
any fall in beta-cell 
compensation.  
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Biomarkers and risk of type II diabetes 
Among the numerous studies in the field of diabetes and insulin resistance research, 
there are a variety of protocols that have been used to analyze abnormalities in glucose 
tolerance.  Common procedures in serum collection and investigation include baseline blood 
samples such as glucose, insulin, glucose challenges, and oral glucose tolerance tests [34, 35, 
46]. Several longitudinal studies successfully highlighted the changes that occur at a cellular 
level that can potentially influence glucose tolerance deterioration.  Among obese adolescents 
with normal glucose tolerance at baseline, beta-cell function was worse both at baseline and 
over the 30 month experimental period amounting in a 20% beta-cell reduction in those who 
progressed to impaired glucose tolerance [35].  Other studies have used similar blood marker 
analysis in reporting that decreasing levels of insulin sensitivity and acute insulin responses 
at baseline in non-diabetic individuals mirrored the glucose intolerance status of subjects with 
type II diabetes at baseline thus suggesting that beta-cell function loss may even appear ten to 
twelve years before diabetes is even diagnosed at the clinical level [47]. Another blood 
marker used in investigations of chronic glucose elevation is hemoglobin A1C (HbA1c). 
HBA1c is considered a convenient marker and a reliable measure of the average glycemic 
levels for the previous 120 days to establish the degree of glucose exposure over time which 
is more intimately related to risk status than single measures of glucose levels [48]. The 
HbA1c assay (standardized and aligned with the Diabetes Control and Complications 
Trial/UK Prospective Diabetes Study assay) has a stronger correlation to co-morbidities than 
that of fasting glucose measurements [48]. Particularly, the prevalence of morbidity increases 
substantially at HbA1c values between 6.0% and 7.0%, while 6.5% signifies a need for a 
diabetic diagnosis [48]. While a study conducted by Lapolla and colleagues indicated that 
fasting plasma glucose levels of >85 mg/dl doubles the risk of a child being born large-for-
gestational-age, it did not show a relation between HbA1c and fetal overgrowth at 24-27 
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weeks of gestation suggesting that HbA1c should not be used as an exclusive reporting 
measure independent of plasma glucose values [34].  Instead, it has been suggested that 
serum glucose values be reported in conjunction with HbA1c in clinical settings to better 
analyze risk for diabetes given that the HbA1c assay does not account for changes in red 
blood cell turnover during pregnancy [48]. Recently, Bozorgmanesh has suggested that type 
II diabetes is not so much an isolated impairment of glucoregulation, but rather a complex 
metabolic consequence of lipid and hepatic fat accumulation [49-51]. A previous cross-
sectional study has also shown that triglyceride concentration is independently associated 
with undiagnosed diabetes [52]. High concentrations of lipoproteins and triglycerides suggest 
complications to insulin sensitivity critical for assessment of diabetes risk status. Low HDL 
cholesterol and high triglycerides may indicate higher risk status while small LDL particles 
and small HDL particles are positively associated with diabetes [53]. A progressive increase 
in insulin resistance has been associated with larger VLDL size, smaller LDL size, and 
smaller HDL size in addition to the elevated concentrations characterizing dyslipidemia [54]. 
In general, glucose, HbA1c, lipoprotein concentrations, and triglycerides have been shown to 
provide considerable laboratory data to reflect insulin sensitivity throughout ethnically 
diverse segments of a population. 
Table 6: Biomarkers and Risk of Type II Diabetes 
Articles Problem/Question 
Studied 
Participants Procedures Findings 
Cali AM, et al. 
Primary defects in 
beta-cell function 
further 
exacerbated by 
worsening of 
insulin resistance 
mark the 
development of 
impaired glucose 
tolerance in obese 
adolescents. 
Diabetes Care. 
2009 
Determine natural 
history of 
progression from 
normal glucose 
tolerance (NGT) to 
IGT in obese 
adolescents. 
Yale 
Pediatric 
Obesity 
Clinic, 60 
obese (>95th 
%ile for 
age/sex) 
adolescents 
with NGT at 
baseline.  
Collected baseline blood samples: 
glucose, insulin, c-peptide, lipid, 
free fatty acids. OGTT performed 
and blood taken every 30 mins for 
180 mins. Measurements of c-
peptide and glucose levels at 10 
and 20 mins of OGTT critical for 
modeling beta-cell function. 
Recorded outcomes of insulin 
sensitivity and beta cell function 
from beta-cell responsitivity 
indexes in addition to body 
composition, weight, height, and 
tanner stage data. 
Beta-cell function worse 
at baseline in progressors 
and over 30 months. 
Beta-cell responsivity 
decreased (20% beta cell 
reduction in progressors). 
Declines in beta-cell 
function are critical 
determinants of 
deteriorating glucose 
tolerance. Central 
adiposity also associated 
with loss of beta cell 
function. 
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Weyer C, et al. 
The natural 
history of insulin 
secretory 
dysfunction and 
insulin resistance 
in the 
pathogenesis of 
type 2 diabetes 
mellitus. J Clin 
Invest. 1999 
Study the sequence 
of glucose 
tolerance 
deterioration. 
Pima 
Indians, a 
population 
with the 
highest 
documented 
prevalence 
of type II 
diabetes in 
the world. 
Measured insulin action, 
insulin secretion, and EGO 
with outcome of glucose 
tolerance deterioration. Body 
fat distribution collected in 
physical exam. Plasma 
glucose concentrations were 
determined by the glucose 
oxidase method. All group 
comparisons adjusted for age 
and sex. 
Development of type 
II diabetes was 
accompanied 
by a marked increase 
in body weight that 
was significantly 
higher than in the 
nonprogressors. 
Festa A, et al. The 
natural course of 
beta-cell function 
in nondiabetic 
and diabetic 
individuals: the 
insulin resistance 
atherosclerosis 
study. Diabetes. 
2006 
Examine 
longitudinal 
changes in beta-
cell function over 
5.2 years by acute 
insulin response 
(AIR) relative to 
insulin sensitivity 
index (Si), as 
assessed from a 
frequently sampled 
intravenous 
glucose tolerance 
test (FSIGTT). 
African-
American, 
Hispanic, 
and non-
Hispanic 
white 
subjects in 
the Insulin 
Resistance 
Atherosclero
sis Study. 
Insulin sensitivity was 
calculated by mathematical 
modeling methods. AIR was 
calculated as the mean plasma 
insulin concentration at 2 and 
4 min after the administration 
of glucose. Height, weight, 
girth, and laboratory 
measurements were 
performed using standard 
methods. Examined 
associations at baseline 
between glucose tolerance, 
insulin sensitivity, and insulin 
secretion. 
Failure to increase 
insulin secretion led to 
IGT, and a decrease in 
insulin secretion led to 
overt diabetes. 
Subjects who 
transitioned from NGT 
to IGT gained weight 
and showed a decline 
in insulin sensitivity 
and a decline in AIR. 
Suggests that 
deterioration in beta-
cell function may 
commence 10–12 
years before diabetes 
is diagnosed. 
Lapolla A, et al. 
Can plasma 
glucose and 
HbA1c predict 
fetal growth in 
mothers with 
different glucose 
tolerance levels? 
Diabetes 
Research and 
Clinical Practice. 
2007 
Assess whether 
HbA1c and plasma 
glucose predicts 
abnormal fetal 
growth. 
758 pregnant 
women 
attending 
Diabetic 
Centers 
screened for 
GDM. 
Glucose challenge (GCT) at 
24-27 weeks gestation: 
normal = control, positive = 
on the day of GCTOGTT and 
classified as abnormal glucose 
value. Also recorded newborn 
birth weight and effects like 
fetal macrosomnia, large for 
gestational age, mean growth 
%ile, pre-pregnancy BMI, and 
fasting plasma glucose 
 Fasting plasma 
glucose at GCT could 
predict fetal 
overgrowth. Plasma 
glucose >85 mg/dl 
doubles risk of LGA 
infants. HbA1c, 
however at 24-27 
gestational weeks does 
not predict fetal 
overgrowth. 
The International 
Expert 
Committee. 
International 
expert committee 
report on the role 
of the A1C assay 
in the diagnosis of 
diabetes. Diabetes 
Care. 2009 
Use the term 
―impaired fasting 
glucose‖ (IFG) to 
differentiate the 
metabolic state 
between a normal 
state (FPG <110 
mg/dl or <6.1 
mmol/l) and 
diabetes (≥126 
mg/dl or ≥7.0 
mmol/l) when the 
FPG test is used. 
__ Recorded prevalence of 
retinopathy as it increases 
substantially at HbA1c values 
starting between 6.0 and 
7.0%. Evaluated convenience 
for the patient and ease of 
sample collection for HbA1c 
testing. Compared this to FPG 
testing (which requires a 
timed sample after at least an 
8-h fast and which is unstable 
at room temperature). Used 
HbA1c assay to diagnose 
diabetes as a reliable measure 
of chronic glycemic levels to 
capture the degree of glucose 
exposure over time related 
more intimately to the risk of 
complications than single or 
episodic measures of glucose. 
Correlation between 
HbA1c levels and 
complications has also 
been shown in the 
setting of controlled 
clinical trials in type 1 
and type II diabetes, 
and these findings 
have been used to 
establish the widely 
accepted HbA1c 
treatment goals for 
diabetes care. May 
serve as a better 
biochemical marker of 
diabetes and should be 
considered a 
diagnostic tool. 
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Mora et al. 
Lipoprotein 
particle size and 
concentration by 
nuclear magnetic 
resonance and 
incident type 2 
diabetes in 
women. Diabetes. 
2010 
Examine the 
association of 
lipoprotein particle 
size and 
concentration with 
clinical type II 
diabetes. 
26,836 
healthy 
women >45 
yrs of age 
drawn from 
the 
Women’s 
Health Study 
(WHS). 
A prospective study that 
followed women for 13 years 
and tracked incidence of type 
II diabetes. Baseline lipids 
were measured and 
lipoprotein size using nuclear 
magnetic resonance 
spectroscopy. Incident clinical 
diabetes was self-reported in 
annual follow-up 
questionnaires and confirmed 
using ADA diagnostic criteria.  
Both triglycerides and 
HDL cholesterol were 
independently 
associated with 
diabetes, and size of 
particles was also 
associated with 
diabetes.  Lipoprotein 
alterations may occur 
years before onset of 
clinical diagnosis of 
diabetes which 
supports potential for 
early detection and 
prevention using these 
markers. 
Kahn HS. The 
lipid 
accumulation 
product is better 
than BMI for 
identifying 
diabetes. Diabetes 
Care 2006. 
Explore whether a 
continuous 
measure of lipid 
accumulation 
performs better 
than BMI in 
identifying insulin 
resistance, elevated 
glucose, and 
diabetes presence. 
Data from 
the 
NHANES 
III including 
4,447 men 
and 4,733 
women >18 
yrs old who 
were not 
pregnant.  
Subjects fasted 8-19 hrs 
before a laboratory 
examination and provided 
data about anthropometry and 
fasted triglycerides. They 
completed an interview and 
were measured for waist 
circumference, serum insulin, 
plasma glucose, and HbA1c. 
Insulin resistance was 
estimated using the 
homeostasis model 
assessment formula and 
diabetes classified as 
physician diagnosis or fasted 
glucose >7.0 mmol/L. 
LAP models were 
consistently, yet 
weakly, superior to the 
BMI models for 
predicting insulin 
resistance risk status. 
The transition from 
moderate loss of 
insulin response to 
diabetic state may be 
more closely linked to 
lipid accumulation 
rather than weight 
gain. The LAP 
combines abdominal 
adiposity and 
circulating 
triglycerides to 
summarize how 
lipotoxicity can lead to 
disease. 
Garvey et al. 
Effects of insulin 
resistance and 
type 2 diabetes on 
lipoprotein 
subclass particle 
size and 
concentration 
determined by 
nuclear magnetic 
resonance. 2003 
Use lipoprotein 
subclasses to 
measure insulin 
resistance among 
individuals with a 
wide range of 
insulin sensitivity 
as a supplemental 
diagnostic tool to 
the conventional 
lipid panel. 
148 
sedentary 
subjects with 
and without 
diabetes 
divided into 
two groups 
based on 
diagnosis 
status after 
weight 
stabilization 
efforts 3 
months prior 
to the study. 
Standard 75g oral glucose 
tolerance tests performed and 
nondiabetic subjects were 
classified as insulin sensitive 
or insulin resistant based on 
glucose uptake rates. % body 
fat measured by dual x-ray 
absorptiometry. In vivo 
insulin sensitivity measure 
using the glucose clamp 
technique and Associations of 
lipoprotein profiles and 
insulin resistance measured 
were analyzed among the 
subjects divided into 3 
categories of disease risk 
status. 
Conventional lipid 
panel did not reflect 
profound differences 
in lipoprotein 
subclasses. As insulin 
resistance becomes 
more severe, VLDL 
size increased while 
LDL and HDL particle 
sizes decreased 
reflecting changes in 
concentrations within 
the lipid profile.  
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Hadaegh F et al. 
High prevalence 
of undiagnosed 
diabetes and 
abnormal glucose 
tolerance in the 
Iranian urban 
population: 
Tehran lipid and 
glucose study.  
BMC Public 
Health 2008. 
Determine the age 
and sex-specific 
prevalence of 
undiagnosed and 
diagnosed 
diabetes, impaired 
fasting glucose, 
impaired glucose 
tolerance in an 
urban population 
and identify 
characteristics of 
individuals to be 
targeted for 
screening 
programs. 
Data from 
the Tehran 
Lipid and 
Glucose 
Study. 
10,368 
people older 
than 20 yrs 
of age living 
in district 13 
of Tehran 
selected by 
multistage 
cluster 
random 
sampling 
methods. 
They did not 
have 
diabetes. 
Subjects were questioned 
about past and family history 
of diabetes. Waist 
circumference was reported 
and BMI calculated. All 
participants fasted 12-14 hrs 
before a blood sample was 
collected. FPG, OGTT, lipids, 
total cholesterol, and 
triglycerides were obtained. 
Low leisure time PA was 
defined as exercising less than 
3 times per week. Participants 
were classified by stages of 
hypertension based on systolic 
and diastolic blood pressure. 
Total prevalence of 
diabetes was higher in 
women than men. 
Triglyceride 
concentration is 
independently 
associated with 
undiagnosed diabetes. 
Screening individuals 
with BMI >25, 
hypertension, and 
abdominal obesity is 
suggested as efficient. 
 
Anthropometric measurements and risk for type II diabetes 
 Obesity is commonly used to imply excess fat, but BMI only modestly performs as a 
predictor of medical risk status as it does not account for where lipid accumulation represents 
an increased physiologic danger [49]. BMI is used for evaluating obesity related risks but can 
not distinguish between fat and lean tissue nor identify anatomical location of fat deposits 
[49]. Central obesity measures, however, have been more closely associated with metabolic 
consequences and shown to precede insulin resistance [50]. These measures including 
circumference ratios such as waist-to-height ratio (WHtR) and waist-to-hip-ratio (WHpR) 
along with the Lipid Accumulation Product (LAP) have been proposed as being more 
informative markers related to chronic disease risk [49]. The LAP is a simple index for 
estimating lipid over accumulation among adults computed using a sex-specific formula 
containing values for waist circumference and triglyceride concentrations [50].The LAP was 
developed to express risk as a continuous function describing the extent to which an 
individual had progressed toward disease risk status in both increased waist circumference 
and plasma triglycerides [50]. In a cross sectional population-based study, the LAP emerged 
as a better predictor than BMI in identifying diabetes [50]. One study indicated that LAP had 
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higher odd ratios for prevalent diabetes than both WHpR and WHtR among women, but the 
LAP has not been validated for use in any lipid accumulation analysis during pregnancy. 
Circumference measures had similar capacity for predicting diabetes and should still be 
included in reporting a diabetic risk profile [49].  
Table 7: Anthropometric Measurements and Risk for Type II Diabetes 
Articles Problem/Question 
Studied 
Participants Procedures Findings 
Bozorgmanesh 
M et al. 
Diabetes 
prediction, 
lipid 
accumulation 
product, and 
adiposity 
measures; 6-
year follow-up: 
Tehran lipid 
and glucose 
study. Lipids in 
Health Disease 
2010. 
Assess if Lipid 
Accumulation 
Product (LAP) 
outperforms BMI 
and circumference 
ratios in 
identifying and 
predicting 
diabetes. 
Data from the 
Tehran Lipid 
and Glucose 
Study of 
individuals not 
assigned to the 
intervention 
study (n=3,931) 
and not 
diagnosed with 
diabetes. 
Data included clinical, 
anthropometric, and 
laboratory measurements 
from baseline examination. 
Standard 2 hr post-
challenge plasma glucose 
test and heath, weight, 
waist circumference, 
plasma glucose and serum 
triglycerides collected. BMI 
calculated and WHpR and 
WHtR calculated. 
Participants were classified 
as having developed 
diabetes during the follow-
up in FPG >7 mmol/l, 2h-
PCPG >11.1 mmol/l or 
taking anti-diabetic 
medications. Subcategories 
for impaired glucose 
tolerance and impaired 
fasting plasma also defined. 
LAP calculated using sex-
specific formula. 
LAP was strong 
predictor of diabetes with 
better predictability than 
BMI. LAP similar in 
predicting incident 
diabetes, however, to 
WHpR and WHtR. 
Individuals with higher 
LAP quartile status had 
increased risk of diabetes 
compared to those with 
low LAP. 
Kahn HS. The 
lipid 
accumulation 
product is 
better than 
BMI for 
identifying 
diabetes. 
Diabetes Care 
2006. 
Explore whether a 
continuous 
measure of lipid 
accumulation 
performs better 
than BMI in 
identifying insulin 
resistance, elevated 
glucose, and 
diabetes presence. 
Data from the 
NHANES III 
including 4,447 
men and 4,733 
women >18 yrs 
old who were 
not pregnant. 
Subjects fasted 8-19 hrs 
before a laboratory 
examination and provided 
data about anthropometry 
and fasted triglycerides. 
They completed an 
interview and were 
measured for waist 
circumference, serum 
insulin, plasma glucose, 
and HbA1c. Insulin 
resistance was estimated 
using the homeostasis 
model assessment formula 
and diabetes classified as 
physician diagnosis or 
fasted glucose >7.0 
mmol/L.  
LAP models were 
consistently, yet weakly, 
superior to the BMI 
models for predicting 
insulin resistance risk 
status. The transition 
from moderate loss of 
insulin response to 
diabetic state may be 
more closely linked to 
lipid accumulation rather 
than weight gain. The 
LAP combines 
abdominal adiposity and 
circulating triglycerides 
to summarize how 
lipotoxicity can lead to 
disease. 
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Pregnancy and insulin sensitivity risk status 
Pregnancy is characterized by endocrine and metabolic adaptations during gestation 
to meet the energy demands of the growing fetus while simultaneously preparing the mother 
for delivery and lactation [20]. Early in pregnancy, metabolism favors lipid deposition in the 
mother while inhibiting lipolysis as placenta hormones such as estrogen and progesterone 
block the action of the mother’s insulin [21]. As this hormonal activity increases in the 
placenta, there is also decreased activity of lipoprotein lipase (LPL) in the adipose and liver 
of the mother which leads to further decreases in insulin sensitivity sparing glucose for the 
fetal growth process [20]. Normal increases in blood volume and metabolites during 
pregnancy add to the increased the demands of glucoregulation, and the pancreas struggles to 
meet the 3- to 3.5-fold greater insulin needed in late pregnancy [22]. Later in pregnancy, there 
is a shift from an anabolic to a catabolic promoting the use of lipids as a maternal energy 
source while preserving glucose and amino acids for the fetus [20]. This process appears as 
dyslipidemia coupled with elevated plasma glucose levels [20, 21]. As insulin action in late 
normal pregnancy is 50–70% lower than in nonpregnant women in response to expected 
increases in plasma glucose, plasma insulin, lipoproteins, and triglycerides, pregnancy 
appears as mimicking a diabetic environment [20]. Interaction with additional metabolic risk 
factors will further express this compromised state of insulin sensitivity conferring significant 
risk of complications to both mother and fetus as the risk for developing diabetes is enhanced 
[20]. Plasma lipid levels also increase with hormonal changes in normal pregnancy, yet 
expected elevations for triglyceride and cholesterol levels during gestation usually do not 
exceed 332 mg/dL and 337 mg/dL, respectively [22]. Specifically in screening methods, the 
data from several studies has shown an increased likelihood of developing abnormal glucose 
tolerance among women with one abnormal glucose value similar to the risk among GDM 
patients with maternal BMI presenting as the strongest co-morbidity predictive factor 
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[25].The physiologic reduction of insulin sensitivity is often accompanied by compensatory 
increase in pancreatic function putting mothers at risk for beta cell exhaustion, and this 
response can be exaggerated in the presence of other predisposing genetic and environmental 
factors associated with insulin resistance such as obesity [25, 55]. The diabetic-like state 
translates to a toxic environment in the womb which potentially promotes abnormal glucose 
tolerance in the growing fetus with both short- and long-term comorbidities. 
Table 8: Pregnancy and Insulin Sensitivity Risk Status 
Articles Problem/Question 
studied  
Participants Procedures Findings  
Fallucca F. 
Pathophysiology 
of diabetes in 
pregnancy. Ann 
Ist Super Sanita. 
1997. 
Examine the 
hormonal 
readjustments in a 
mother during 
pregnancy that 
maintain the 
metabolic state yet 
impinge on 
diabetes 
prevention. 
---- Review the 
literature that exists 
and endocrinologic 
and metabolic 
adaptations during 
pregnancy in 
women with normal 
carbohydrate 
metabolism. 
Describe the 
characteristics of a 
compromised 
―milieu‖.  
Pregnancy results in 
compromised 
glucoregulation capacity 
from fetal blood and 
amniotic fluid changes in 
addition to hormonal 
production in the placenta. 
Disturbances of 
intermediary metabolism 
play a role in etiology of a 
diabetic pregnancy. 
Basaran A. 
Pregnancy-
induced 
hyperlipoproteine
mia: review of 
literature. Reprod 
Sci. 2009. 
Examine literature 
related to above 
average elevations 
in lipoproteins, 
triglycerides, and 
cholesterol during 
pregnancy and 
how to screen for 
this during 
pregnancy 
Two groups of 
patients with 
elevations over 
the 95%ile 
categorized as 
having 
hyperlipoprotein
emia during 
pregnancy or 
extreme cases 
limited to a 
gestational 
period.  
Underlying 
disorders were 
identified in each of 
the two groups of 
patients with 
degrees of 
hyperlipoproteinemi
a. 
Expected elevations for 
triglyceride and cholesterol 
levels during normal 
gestational period do not 
exceed 332 mg/dL and 337 
mg/dL. If above the 95%ile, 
women may be at higher 
risk for developing 
hyperlipoproteinemia later 
in life. 
Corrado F et al. 
Positive 
association 
between a single 
abnormal glucose 
tolerance test 
value in 
pregnancy and 
subsequent 
abnormal glucose 
tolerance. 
American Journal 
of Obstetrics and 
Gynecology. 
2007. 
 
Study the long-
term prevalence of 
abnormal glucose 
tolerance and the 
associated 
predictive risk 
factors among 
women with a 
single abnormal 
glucose tolerance 
test value during 
pregnancy. 
Three groups: 
58 women with 
GDM, 66 with a 
single abnormal 
value in a 
glucose 
tolerance test, 
and 56 control 
women.  
All women tested 
with a 75g oral 
glucose tolerance 
test at a mean of 6.9 
years postpartum. 
Maternal-fetal 
outcomes were 
taken from medical 
charts. Glucose was 
measured by the 
glucose oxidase 
method from venous 
plasma samples.  
There is an increased 
likelihood of developing 
abnormal glucose tolerance 
in women with one 
abnormal glucose value 
similar to GDM patients 
with BMI presenting as the 
strongest predictor. 
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Dalfra MG et al. 
Antepartum and 
early postpartum 
predictors of type 
2 diabetes 
development in 
women with 
gestational 
diabetes mellitus. 
Diabetes Metab 
(Paris). 2001. 
Identify pre-
pregnancy and 
early post-partum 
clinical and 
metabolic 
characteristics with 
predictive potential 
in the future 
development of 
type II diabetes. 
Subjects 
selected from a 
group of 650 
women screened 
for GDM in a 2 
year time 
period. 70 
women with 
GDM included 
in the sample. 
Screening in all 
patients between the 
24th and 28th weeks 
of pregnancy using 
the glucose 
challenge test. 
GDM diagnosed if 
any fasting glucose 
>95 mg/dl or 
abnormal test 
values. Recorded 
age, family history 
of diabetes, pre-
pregnancy BMI, and 
previous pregnancy 
outcomes. Type of 
delivery noted, and 
HbA1c from 3rd 
trimester, weight 
gain, and presence 
of insulin therapy 
also recorded. 
OGTT every year 
for 5 years after 
delivery. 
One yr after pregnancy, 7 
of 70 GDM patients 
developed IGT and 6 of the 
70 5 yrs after delivery. 
Only pre-pregnancy obesity 
was more common in 
women with post-partum 
diabetes. Patients who 
developed IGT after 
pregnancy had higher 
fasting plasma glucose 
values.  
Di Cianni et al. 
Intermediate 
metabolism in 
normal pregnancy 
and in gestational 
diabetes. Diabetes 
Metab Res Rev 
2003. 
Identify the normal 
hormonal changes 
during pregnancy 
and how they 
create a decline in 
insulin action with 
compensatory 
increases in insulin 
secretion and 
elevated plasma 
glucose levels. 
--- Changes analyzed in 
insulin resistance, 
insulin secretion, 
associated hormone 
secretion, glucose 
metabolism. 
Gestational diabetes 
characteristics noted 
and factors 
associated with 
GDM identified as 
abnormalities in 
glucose 
homeostasis. Lipid 
metabolism in 
normal pregnancy 
compared to GDM 
and protein 
metabolism 
processes described 
using past literature. 
Insulin resistance develops 
in the 2nd and 3rd trimesters 
making pregnancy a 
diabetogenic condition.  
These changes are 
necessary for maternal 
metabolic efficiency and 
distributing nutrients to the 
fetus.  
 
Physical activity and diabetes risk factors 
 
The literature is saturated with research showcasing the benefits of physical activity.  
Many studies have demonstrated the attenuating association between regular physical activity 
and chronic insulin sensitivity issues [9, 23, 38, 56]. Research has shown that participating in 
regular physical activity has a protective effect against developing multiple types of insulin 
resistance in addition to clinically-diagnosed diabetes [23, 39]. For example, higher levels of 
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physical activity have been associated with lower insulin areas in individuals with impaired 
glucose tolerance even after adjusting for confounders such as obesity and glucose levels 
with the strongest protective effects appearing in individuals at highest risk due to high BMI, 
history of hypertension, and parental histories of diabetes [38, 39].  It has been documented 
that as little as 30 MET hours/week increments of activity are associated with a 10% decrease 
in insulin area and lower fasting insulin levels [38]. In terms of physical activity reducing risk 
of diabetes during pregnancy, the literature suggests that recreational physical activity before 
and/or during pregnancy is associated with reduced risk of developing GDM such that 
women exercising regularly during the first 20 weeks of pregnancy experienced a 48% 
reduction in risk [23]. Even among the Latina population in which there are significantly 
lower levels of activity reported during pregnancy, higher pre-pregnancy and mid-pregnancy 
household and sport activity has been associated with a reduced risk of GDM [56]. More 
research is needed in this domain, however, to standardize the measurement of physical 
activity across various studies for comparison purposes as well as operationalize the 
definitions of leisure-time physical activity and habitual physical activity.  Yet, even despite 
the differences and limitations, there is a well-established correlation between physical 
activity and risk reduction for insulin resistance above and below clinical diabetes diagnosis. 
Table 9: Physical Activity and Diabetes Risk Factors 
Study Question/Problem 
Studied 
Participants Procedures Findings 
Hegaard HK, et 
al. Leisure time 
physical activity 
during pregnancy 
and impact on 
gestational 
diabetes mellitus, 
pre-eclampsia, 
preterm delivery 
and birth weight: 
a review. Acta 
Obstet Gynecol 
Scand. 2007 
To review 
prevailing 
literature to 
describe the 
association 
between LTPA and 
GDM  pre-
eclampsia, preterm 
delivery, and birth 
weight 
GDM: 10 
studies; Pre-
eclampsia: 10 
studies; Preterm 
delivery: 6 
studies; Birth 
Weight: 23 
studies; Strength 
Conditioning: 2 
studies. 
Examine 
prevalence/impact on 
GDM, pre-eclampsia, 
preterm delivery, and 
birth weight with 
physical activity 
exposure and energy 
intake. 
Women performing LTPA 
during and/or before 
pregnancy had a better or 
unchanged outcome in 
relation to GDM, pre-
eclampsia, preterm delivery 
and birth weight; protective 
effect seems to increase with 
intensity of and time spent on 
physical activity with GDM 
and Pre-eclampsia; no 
evidence for increased risk of 
poor pregnancy outcome with 
physical activity. 
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Chasen-Taber L, 
et al. Physical 
activity and 
gestational 
diabetes mellitus 
among hispanic 
women. Journal 
of Women's 
Health. 2008 
Examine 
relationship 
between various 
types of physical 
activity during 
pregnancy time 
periods and risk of 
GDM in Hispanic 
women. 
1006 Hispanic 
(predominantly 
Puerto Rican) 
prenatal care 
patients 2000 to 
2004. 
GDM screening and 
interviews 28 wks 
gestation. Activity 
indices created for 
each domain of 
activity by summing 
the domain-specific 
categorical responses 
and getting an 
average value then 
total activity 
calculated by 
weighted sum of each 
activity index. Final 
models adjusted for 
age and BMI. 
Lower levels of activity 
during pregnancy for Hispanic 
compared to non-Hispanic. 
No association between 
occupational and active living 
activities pre-pregnancy, 
early-, or mid-pregnancy and 
risk of GDM. But after 
controlling for age and pre-
pregnancy BMI, higher prep-
pregnancy and mid-pregnancy 
household and sport activity 
associated with reduced risk 
GDM. Consistent with 
findings in non-Hispanic 
white populations that 
physical activity reduces risk 
status. 
Regensteiner JG, 
et al. Relationship 
between habitual 
physical activity 
and insulin area 
among 
individuals with 
impaired glucose 
tolerance. The 
San Luis Valley 
Diabetes Study. 
Diabetes Care. 
1995 
Determine whether 
higher levels of 
physical activity 
are associated with 
lower fasting 
insulin levels and 
lower insulin areas 
under the oral 
glucose tolerance 
curve in 
individuals with 
impaired glucose 
tolerance (IGT) 
219 Hispanic 
and non-
Hispanic white 
men and women 
with IGT (by 
WHO criteria) 
in rural 
Colorado ages 
20-74. 
Measured total PA 
(7-day PA recall and 
MET hrs/wk). MET 
values assigned to 
activities. Fasting 
insulin levels 
collected and insulin 
area calculated with 
trapezoidal rule. 
Fasted glucose 
recorded and IGT 
noted (fasting 
glucose <140 mg/dl 
and 2hr glucose 140-
199 mg/dl).  
Higher levels of habitual 
physical activity associated 
with lower insulin areas in 
people with IGT. This 
persisted even after adjusting 
for confounders including 
obesity and glucose levels. 
Suggests physical activity is a 
determinant of glucose 
tolerance and insulin 
resistance. 30 MET hrs/wk 
increment in activity 
associated with 10% decrease 
in insulin area.  
Helmrich SP, et 
al. Physical 
activity and 
reduced 
occurrence of 
non-insulin-
dependent 
diabetes mellitus. 
N Engl J Med. 
1991 
Examine 
effectiveness of 
physical activity in 
preventing non-
insulin-dependent 
diabetes mellitus 
(NIDDM). 
5990 male 
alumni of 
University of 
Pennsylvania 
from 1962 to 
1976. 
Used questionnaires 
of physical activity 
patterns and recorded 
development of 
NIDDM. 
Correlations, 
incidence rates, age-
adjusted risk of 
NIDDM and 
calculated in addition 
to relative risks. 
Protective effect of physical 
activity was strongest in 
individuals at highest risk of 
NIDDM (high BMI, history of 
hypertension, parental history 
of diabetes). Other predictor 
also weight gain since college.  
Dempsey JC, et 
al. A case-control 
study of maternal 
recreational 
physical activity 
and risk of 
gestational 
diabetes mellitus. 
Diabetes Res Clin 
Pract. 2004 
Identify modifiable 
risk factors for 
GDM. 
155 GDM and 
386 non-diabetic 
controls. 
Evaluated 
recreational physical 
activity one year 
before and during the 
first 20 weeks of 
pregnancy (type, 
intensity, frequency, 
duration in each time 
period) and 
calculated risk of 
GDM using odds 
ratios. 
Recreational physical activity 
before and/or during 
pregnancy associated with 
reduced risk of developing 
GDM. 
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Physical activity during pregnancy and maternal/offspring benefits 
The breadth and depth of our understanding of the relationship between physical activity 
and positive pregnancy outcome has substantially increased in recent years and is continuing 
to escalate. The American College of Obstetricians and Gynecologists highlight the 
importance of exercise as medicine by recommending that all pregnant women participate in 
at least 150 minutes per week of moderate intensity physical activity throughout pregnancy 
[57].  This volume is based on the expectation that women will experience a variety of 
maternal benefits such as reducing hypertension, risk for preterm delivery, and gestational 
diabetes [9, 10, 57]. Recently, physical activity during pregnancy has been associated with 
reduced risk of GDM among Latina women [56].  Furthermore, the protective effects elicited 
from engaging in physical activity seem to increase as intensity and duration are elevated [9].  
Current literature also indicates that maternal leisure-time physical activity (LTPA) before 
and during pregnancy has several potential offspring benefits in that it is associated with 
reduced birth weight within the normal range and lower risk for being born large-for-
gestational-age [9-11].  The results of earlier research studies have indicated that offspring of 
women who exercised vigorously throughout pregnancy continued to have significantly less 
body fat at five years of age compared to offspring of women who were sedentary during 
pregnancy [40].  Studies have also been conducted to reassure pregnant women that 
participating in physical activity during pregnancy has not been associated with postnatal 
growth deficits or growth restriction even in children of exercising women at five years of 
age [40, 58]. Contemporary research has also explored the mechanisms proposed to elicit the 
positive association between physical activity later in pregnancy and the lower risk for an 
infant being born large-for-gestational-age. Moreover, because physical activity during the 
second and third trimesters appears to lower the risk for macrosomnia and the quantity of 
gestational weight gain, it has been proposed that physical activity later in pregnancy 
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coincides with fetal growth patterns in the period of highest uterine weight gain and thus has 
greater effects on glucose tolerance, insulin sensitivity, and offspring size at that time [10, 
59].  
With more research being conducted to outline how physical activity patterns influence 
maternal benefits and offspring outcomes across various ethnic populations, it is critical to 
not only investigate the possibility of a ―threshold‖ of beneficial physical activity during 
pregnancy but also establish validated methods of measurement [60].  The Modifiable 
Activity Questionnaire (MAQ) is a validated instrument used to assess maternal LTPA [61]. 
The MAQ was created for the purpose of LTPA recall and has been validated for use with 
women recalling pregnancy related LTPA six years postpartum [62]. This method asks study 
participants to recall a typical week of LTPA for several time points before, during, and after 
pregnancy. Using durations (min/d) and frequencies (d/wk) reported for each activity, MET 
values are assigned based on the compendium of physical activities [63, 64].  Numerically 
quantifying the volume of physical activity in a standardized and validated fashion allows for 
comparison to ACOG recommendations as well as statistical analysis both within and 
between experimental groups.  
Table 10: Physical Activity During Pregnancy and Maternal/Offspring Benefits 
Articles Problem/Question 
Studied 
Participants Procedures Findings 
Hegaard HK, et 
al. Leisure time 
physical activity 
during pregnancy 
and impact on 
gestational 
diabetes mellitus, 
pre-eclampsia, 
preterm delivery 
and birth weight: 
a review. Acta 
Obstet Gynecol 
Scand. 2007 
 
To review 
prevailing literature 
to describe the 
association between 
LTPA and GDM  
pre-eclampsia, 
preterm delivery, 
and birth weight 
GDM: 10 
studies; Pre-
eclampsia: 10 
studies; 
Preterm 
delivery: 6 
studies; Birth 
Weight: 23 
studies; 
Strength 
Conditioning: 2 
studies. 
Examine 
prevalence/impact 
on GDM, pre-
eclampsia, preterm 
delivery, and birth 
weight with 
physical activity 
exposure and 
energy intake. 
Women performing LTPA 
during and/or before pregnancy 
had a better or unchanged 
outcome in relation to GDM, 
pre-eclampsia, preterm delivery 
and birth weight; protective 
effect seems to increase with 
intensity of and time spent on 
physical activity with GDM 
and Pre-eclampsia; no evidence 
for increased risk of poor 
pregnancy outcome with 
physical activity. 
30 
 
 
 
Alderman BW, et 
al. Maternal 
physical activity 
in pregnancy and 
infant size for 
gestational age. 
Ann Epidemiol. 
1998 
To estimate the 
effect of several 
types of maternal 
physical activity in 
pregnancy on size 
for gestational age 
and length of 
gestation. 
291 Colorado 
residents. 
Recorded 2nd and 
3rd trimester 
physical activity in 
addition to size for 
gestational age and 
gestational length. 
Divided into 7 
categories: 
demographic, 
obstetrical and 
gynecological, 
anthropometric, 
pregnancy 
complications, 
environmental, 
infant, and medical 
record review.  
Physical activity during 2nd 
and 3rd trimesters associated 
with lower risk of infant large 
for gestational age; Association 
was confirmed between higher 
pre-pregnancy maternal weight 
and LGA infants and an 
association between ethanol 
use and increased risk of small 
for gestational age.  Potential 
Mechanism: Physical activity 
affects glucose tolerance and 
insulin sensitivity. 
Perkins CC, et al. 
Physical activity 
and fetal growth 
during pregnancy. 
Obstet Gynecol. 
2007 
To assess separate 
and combined 
relationships of 
aerobic physical 
activity during 
pregnancy, maternal 
weight gain during 
pregnancy, and 
height to the fetal 
growth ratio. 
51 healthy non-
smoking 
women. 
Measured physical 
activity at 20 and 
32 weeks. 
Maternal weight 
gain, maternal 
height in addition 
to offspring 
measures of birth 
weight, fetal 
growth ratio 
(divide birth 
weight by median 
birth weight for the 
gestational week - 
adjusting for 
gender, race, and 
parity). 
Fetal growth ratio was not 
affected by activity levels as 
strongly in shorter women as it 
was in taller women. Physical 
inactivity may be a risk factor 
for excessive growth in taller 
women or fetal growth may be 
constrained by maternal size in 
shorter women. 
Clapp JF. The 
morphometric and 
neurodevelopmen
tal outcome at 
five years of the 
offspring of 
women who 
continued 
exercise 
throughout 
pregnancy. J 
Pediatr. 1996 
Examine how 
regular, vigorous, 
sustained exercise 
during pregnancy  
affects birth and 
offspring outcomes 
at 5 years. 
20 exercising 
women, 20 
physical 
activity 
controls.  
Examine between-
group differences 
for morphometric 
parameters and 
tested the effect of 
exercise volume on 
outcomes. 
Negate initial hypothesis. No 
evidence of growth restriction 
at 5 years in offspring of 
exercising women. Children of 
exercising women had height 
and weight in 50th %ile for 
age, and skinfold and upper 
arm fat in 45th and 60th %iles. 
Offspring in control are on the 
fat side, not that exercise group 
is low. 
American college 
of obstetricians and 
gynecologists. 
ACOG committee 
opinion. Exercise 
during pregnancy 
and the postpartum 
period. Int J 
Gynaecol Obstet. 
2002 
To review clinical 
and scientific 
advances and update 
physical activity 
recommendations for 
women during 
pregnancy and 
postpartum. 
__ Evaluated the 
numerous adverse 
and beneficial 
maternal and fetal 
outcomes with 
physical activity 
(occupational and 
leisure). 
Sports should be reviewed 
individually for relative risks. 
Recreational/competitive athletes 
can remain active if 
uncomplicated pregnancy and 
medically supervised. Previous 
inactive women may benefit from 
physical activity (decreased 
GDM risk). Physical activity 
should be reduced in 2nd and 3rd 
trimester if history of preterm 
labor or fetal growth restriction. 
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Pivarnik JM 
1998. Potential 
effects of 
maternal physical 
activity on birth 
weight: brief 
review. 
To discuss the 
relationship (if any) 
of maternal physical 
activity on birth 
weight and suggest 
directions for future 
research. 
7 studies 
(occupational 
physical 
activity and 
birth weight) 
13 studies 
(leisure time 
physical 
activity and 
birth weight). 
Evaluated job 
related and leisure 
time physical 
activity in relation 
to birth weight and 
gestational length 
as offspring 
outcomes. Also 
recorded maternal 
weight gain, 
dietary intake, and 
socioeconomic 
status data. 
Some studies have shown job 
related physical activity to be 
related to unfavorable birth 
outcomes but most did not 
control for SES or quantify 
activity throughout gestation. 
Results of the relationship 
between leisure time physical 
activity and birth weight are 
mixed – physical activity 
measurement and caloric 
measurement must be more 
carefully quantified to 
investigate a "threshold. 
Lof et al. 2007. 
Effects of pre-
pregnancy 
physical activity 
and maternal BMI 
on gestational 
weight gain and 
birth weight 
Assess relationships 
between pre-
pregnancy physical 
activity level 
(PAL), BMI and 
gestational weight 
gain (GWG) during 
the 2nd and 3rd 
trimester and to 
determine the 
effects of pre-preg 
PAL, BMI and 
GWG on birth 
weight. 
223 healthy 
Swedish 
women in 
gestational 
weeks 12, 25, 
and 33. 
Recorded 
gestational weight 
gain in 2nd and 3rd 
trimesters; 
offspring birth 
weight, BMI and 
pre-pregnancy 
characteristics. 
Season of the year, 
parity, smoking, 
age, and education 
of the mother were 
all controlled for in 
analysis. 
The majority of women 
exceeded recommendations for 
GWG during the 2nd and 3rd 
trimesters. No association 
between PAL and birth weight 
was noted. High BMI and 
GWG linked to high birth 
weight. High PAL was 
associated with lower GWG in 
3rd, but not 2nd trimester. 
Higher BMI gained less weight 
during 2nd, but more weight 
during 3rd trimester than 
women with lower BMIs. 
Clapp JF et al 
1998. The one-
year 
morphometric and 
neuodevelopment
al outcome of the 
offspring of 
women who 
continued to 
exercise regularly 
throughout 
pregnancy 
Determine if regular 
exercise throughout 
pregnancy alters 
birth and offspring 
outcomes at 1 year. 
52 exercise 
women and 52 
control (25 - 38 
yrs, 12-28%fat) 
Clinically 
normal 
antenatal and 
postnatal. And 
124 offspring. 
Morphometrics 
collected 24 hrs 
after birth: weight, 
length, 
circumferential 
head/neck/ab, 
triceps and 
subscapual 
skinfold in the 
offspring as well 
as fat mass. The 
study sample of 
mothers were 
monitored for 
exercise, dietary 
intake, weight 
gain, and 
physiological 
responses as they 
exercised 3 x week 
20+ min at 55% 
intensity. Maternal 
weight, height, and 
pre-pregnancy 
fitness recorded.  
Offspring of exercising 
mothers have normal growth in 
first year. Compared to national 
cohorts, they had height, 
weight, and fat mass at or near 
the 50th %ile. No deficits in 
any aspect of postnatal growth 
after 1 year for offspring of 
exercisers. 
  
 
Chapter III 
 
Methodology 
 
Subjects 
 
Women who were currently pregnant aged 19-35 living in Harrisonburg-Rockingham 
County and the surrounding areas were recruited for this study. Lead investigators met with 
staff from the Virginia state health department, the Special Supplemental Nutrition Program 
for Women, Infants, and Children (WIC) program, local OBGYN clinics, local private 
birthing and midwifery clinics, yoga studios, and area food banks during the recruitment 
process to promote and explain the study. With approval from all staff involved, information 
pamphlets and flyers about the study were distributed on-site available in both English and 
Spanish.  All interested individuals were asked to contact the Morrison-Bruce Center for the 
Promotion of Physical Activity for Girls and Women (MBC) at James Madison University.  
The women who contacted the MBC and met the study criteria composed the sample for this 
study. Lead investigators contacted all participants to schedule testing appointments during 
the data collection period. Informed consent was obtained from every participant per the 
James Madison University Institutional Review Board. 
Testing Procedures 
 
 Once enrolled in the study, women reported to the laboratory for one testing session. 
Gestational duration of pregnancy was recorded during the testing session, and each woman 
was categorized by trimester or post partum status. The one hour testing session involved a 
venous blood draw in addition to completing a series of questionnaires and collecting 
measurements including height, weight, hip/waist circumferences, resting blood pressure, and 
resting heart rate. Participants were also given a pedometer and pedometer logbook prior to 
departure from this session and asked to record their daily step counts for two weeks to 
minimize the Hawthorne effect in the first 1-2 days of pedometer usage.. All women were 
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shown how to operate the pedometer and instructed to wear it in a modified lateral hip 
location to avoid vertical displacement disturbances during pregnancy in the standard mid-
thigh-line frontal position. Upon returning the logbook data, women were given the option to 
either keep the pedometer or receive diapers in addition to reading materials with information 
related to physical activity, nutrition, and breastfeeding during pregnancy and postpartum as 
compensation for their voluntary participation in the study. 
Anthropometric Measurements 
Height was measured using a stadiometer to the nearest 0.5 centimeter. Weight was 
measured to the nearest 0.10 kilogram. Hip and waist circumference measures were modified 
to be collected above and below the fetal growth area and conducted until two measures 
within 5 millimeters of each other were recorded. Current waist-to-hip ratio (WHpR) and 
waist-to-height ratio (WHtR) for each participant were then calculated using these measures. 
Resting blood pressure and resting heart rate were measured using standardized procedures 
after each participant had been resting in an reclined position for 10 minutes. The same 
investigator collected anthropometric measures for all participants throughout the study.  
Quantifying Physical Activity 
Women were asked to complete the Modifiable Activity Questionnaire (MAQ) to 
assess maternal leisure time physical activity (LTPA)[61]. The MAQ has been validated and 
is an acceptable tool for estimating LTPA with women recalling pregnancy related LTPA six 
years postpartum [62]. Participants recalled a typical week of LTPA for the 12-month time 
period prior to the testing session. From a list of forty activities, women selected activities 
that they participated in more than ten times in the past year and reported average durations 
(min/day) and frequencies (day/wk) for each activity.  MET values were assigned to each of 
the chosen activities based on the compendium of physical activities [63, 64]. Volume of 
LTPA was calculated by multiplying the reported frequency and duration by the MET value 
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of each activity (MET·min/wk). The American College of Obstetricians and Gynecologists 
(ACOG) recommends that pregnant women participate in at least 150 minutes per week of 
moderate intensity LTPA[57]. Thus, women were classified as meeting ACOG 
recommendations if their average pregnancy volume of leisure time physical activity met or 
exceeded 450 MET·min/week (i.e., the equivalent of 3 METS * 30 min/d * 5 d/wk) in the 
trimester of their lab visit.  
Total step counts for multiple time periods in addition to weekly averages, weekday 
averages, and weekend averages were calculated from the daily step count data in the 2-week 
pedometer logs for all participants. Women were classified as sedentary (<5000 steps/day), 
low active (5000-7499 steps/day), somewhat active (7500-9999 steps/day), active (≥10000 
steps/day), or highly active (>12500 steps/day) based on their average step counts per day 
during the two week data collection period following the blood draw [65]. All women in any 
of the active categories were then more generally dichotomized and classified as ―active‖ 
(>5,000 steps/day). 
Serum Markers of Insulin Resistance 
A venous blood sample was obtained after an 8-hour fast via venapuncture of the 
antecubital vein after participants had been seated in a full inclined position for 15 minutes 
[38]. Approximately 29 mL of blood was required in order to analyze the dependent serum 
markers of insulin sensitivity influencing the risk for diabetes including fasted glucose 
(BGlu), glycosylated hemoglobin (HbA1c), total cholesterol (TCHOL), low density 
lipoprotein cholesterol (LDLC), high density lipoprotein cholesterol (HDLC) and 
triglycerides (TGs). Two variables (HbA1c and BGlu) were analyzed immediately from 
whole blood.  Plasma was separated from the serum collection tubes after a 30 minute 
incubation period and 20 minutes in a centrifuge.  Serum was then frozen in serum tubes at -
80ºC. After measurement of TCHOL, HDL, and TGs, the Friedewald equation was used to 
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predict LDLC values for all subjects calculated as TCHOL minus HDL minus (TGs ÷ 5) [66, 
67]. 
The American Diabetes Association, the International Diabetes Federation, and the 
European Association for the Study of Diabetes have determined that individuals with 
HbA1c levels between 6.0% and 6.5% should be cautioned that they are in the highest risk 
group for developing type II diabetes [48]. Therefore, women in this study were classified in 
a diabetes risk stratification based on serum concentrations of HbA1c. Insulin resistance is a 
critical determinant of diabetes-related pregnancy risk status among fertile Caucasian and 
Latina women. Pregnant women, for instance, who are not clinically diagnosed with 
Gestational Diabetes Mellitus (GDM) but show serum indications of milder insulin 
resistance, may still be considered at a higher risk during pregnancy for diabetes-related 
complications and offspring outcomes [32-35]. Together, these biomarkers can reveal the 
progressive loss of insulin-secreting function, insulin receptor desensitization, and elevated 
blood glucose associated with type II diabetes [32-34]. 
Statistical Analysis 
 
 Descriptive statistics were calculated for all independent, dependent, and participant 
variables. Median, range, mean, and standard deviation are reported for all continuous 
variables (i.e. current age, height, weight, WHpR, WHtR, MET·mins/wk, gestational age) 
and frequencies and percentages were computed for all categorical variables (i.e. meeting or 
not meeting ACOG recommendations, step count classifications).  The dependent outcome 
variables in this study were HbA1c, BGlu, HDL, LDL, TCHOL, and TGs. Six scatter plots 
were created to display each woman’s biomarker value on the y-axis in relation to week of 
gestation on the x-axis. Linear regression then constructed the lines of best fit for two groups 
of datapoints depending on whether women were meeting or not meeting physical activity 
recommendations (expressed as both the ACOG recommendation equivalent to 450 
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MET·mins/week during pregnancy and ―active‖ step count classification equivalent to >5,000 
steps/day) at the time of the testing appointment. The slopes and intercepts of the two 
regression lines for meeting and not meeting both ACOG and ―active‖ step count 
classification were then compared for differences among each dependent biomarker. The 
correlation between the two measures of physical activity (MAQ and step counts) was also 
examined. Additionally, SPSS version 18.0 was used for univariate (ANCOVA) analysis. 
The linear regression univariate models between biomarkers and continuous physical activity 
evaluated the significance of physical activity as a predictor of a biomarker value after 
accounting for gestational age as the covariate. A two-tailed alpha level of p < 0.05 indicated 
statistical significance with p<0.1 approaching significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter IV 
Manuscript 
 
ABSTRACT  
BACKGROUND: Changes in maternal insulin sensitivity throughout pregnancy 
may help supply nutrients to a growing fetus; however, the changes may concomitantly 
increase the mother and child’s risk for diabetes and chronic diseases.  Regular physical 
activity (PA) positively impacts precursors for diabetes, but the impact of PA throughout 
gestation is less studied. The purpose of this study was to examine the relationship between 
meeting PA recommendations and diabetes risk in pregnant women. METHODS: A total of 
23 pregnant women were recruited for participation. Venous blood samples, questionnaires, 
and anthropometric measurements (height, weight, and hip/waist circumferences) were 
ascertained during a single session. Participants also completed the MAQ physical activity 
recall questionnaire and wore a pedometer to record current PA. Daily step counts were 
recorded using a pedometer for two weeks following the blood draw.  Women were classified 
as meeting American College of Obstetrics and Gynecology (ACOG) recommendations 
(>450 MET·min/week) and/or ―active‖ (>5000 steps/day) based on their average steps/day. 
Blood samples were analyzed for levels of glucose (BGlu), glycosylated hemoglobin 
(HbA1c), total cholesterol (TCHOL), low density lipoprotein cholesterol (LDLC), high 
density lipoprotein cholesterol (HDLC) and triglycerides (TGs). Scatter plots were 
constructed for each biomarker versus gestational week to analyze differences in slopes and 
intercepts between two physical activity level groups. RESULTS: At the blood draw, 15 
(65.2%) women were meeting ACOG physical activity recommendations and 7 (36.8%) met 
an ―active‖ step count classification. Meeting activity recommendations was not significantly 
related to any biomarker after controlling for gestational age in univariate  analysis, but an 
―active‖ daily step count approached significance in predicting HbA1c values (p=0.067). In 
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scatter plot regression, there were significant differences in slopes for LDL (M0 – M1 = 
7.357, p=0.032) and total cholesterol (M0 – M1 = 7.568, p=0.043) based on meeting or not 
meeting step count recommendations. Difference in intercepts from ACOG recommendations 
approached significance for HDL (-22.84, p=0.076). CONCLUSIONS: These results 
provide preliminary support that meeting or not meeting physical activity recommendations 
during pregnancy may be related to the progression of LDL, cholesterol, HDL, and HbA1c 
biomarkers for diabetes risk factors throughout gestation. 
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INTRODUCTION 
The prevalence of obesity for children ages 6-11 years has increased from 6.5% in 
1980 to 19.6% in 2008[1]. Obesity during childhood is associated with poor health, including 
a high risk of obesity tracking into in adolescence and adulthood [2, 3]. Investigations 
indicate that the risk of high birth weight infants remaining overweight in childhood is more 
than that of non-overweight infants [4, 5]. Thus, offspring size is noted as an early indication 
of child weight status, and several perinatal factors such as parental body mass index (BMI), 
excess weight gain during pregnancy, and maternal gestational diabetes mellitus (GDM) are 
associated with risk for being born large for gestational age [6-12].   
The connection between GDM and offspring size is a significant health concern due 
to the increased risk for diabetes and other chronic diseases and conditions for both mother 
and child (e.g. CVD, cancer, gall bladder disease, etc) [13-16]. Offspring born to mothers 
with GDM not only suffer from increased risk of infant morbidity and obesity, but gestational 
exposure to glucose intolerance is also strongly linked to the future development of type II 
diabetes in the offspring [12, 17-19]. Reported rates of GDM in the United States range from 
2% to 10% of pregnancies, and women who have had GDM also have a 35% to 60% chance 
of developing diabetes in the 10-20 years after pregnancy [71]. The physiology of pregnancy 
inherently compromises maternal insulin sensitivity as a presumable strategy to supply 
adequate fuel sources to the growing fetus [20]. Early pregnancy favors lipid deposition in 
the mother while inhibiting lipolysis as placenta hormones such as estrogen and progesterone 
aid fetal growth but partially block the action of the mother’s insulin [21]. As hormonal 
activity increases in the placenta, there is decreased activity of lipoprotein lipase (LPL) in 
adipose tissue and liver which leads to further decreases in insulin sensitivity as glucose is 
spared for the fetus [20]. Normal increases in blood volume during pregnancy further 
imposes a level of stress to the glucoregulatory system and the pancreas struggles to meet the 
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3- to 3.5-fold greater insulin needed in late pregnancy [22]. Late in pregnancy, a shift from a 
lipogenic-state promotes lipid oxidation for maternal energy while preserving glucose and 
amino acids for the fetus [20]. This fuel regulation process appears as a 3-fold increase in 
plasma triglycerol concentrations during the 3rd trimester and delayed postprandial clearance 
of fatty acids coupled with elevated plasma glucose levels [20, 21]. Thus, insulin action late 
in a normal pregnancy is 50–70% lower than in non-pregnant women in response to expected 
increases in plasma glucose, plasma insulin, lipoproteins, and triglycerides mimicking a 
diabetic environment [20]. This normal progression of insulin resistance during pregnancy 
can become an issue of concern. At the present time, more women are becoming pregnant at 
higher starting weights and gaining excess weight beyond healthy gestational weight gain 
recommendations which will exacerbate diabetic risk status [23-25].  
Insulin resistance is thus a critical determinant of diabetes-related pregnancy risk 
status among a diverse population of fertile women. Pregnant women, for instance, who are 
not clinically diagnosed with GDM but show serum indications of milder insulin resistance, 
may still be considered at a higher risk during pregnancy for diabetes-related complications 
and offspring outcomes [33-36]. Elevated LDL in the plasma lipid profile, large waist 
circumferences and anthropometric ratios, and chronically high hemoglobin A1c (HbA1c) 
percentages can reveal increased risk for insulin receptor desensitization and elevated blood 
glucose associated with type II diabetes [33-35]. In 2005-2008, based on fasted glucose or 
HbA1c levels, 35% of adults in the United States aged 20 years or older had prediabetes [71]. 
As a potential avenue for attenuating both biochemical and anthropometric risk status, 
participation in regular physical activity may help an individual reduce excess body fat and 
improve overall body composition[37]. Moreover, regular physical activity is known to 
positively impact precursors for diabetes [23, 38, 39]. Current literature indicates that 
maternal leisure-time physical activity (LTPA) before and during pregnancy is associated 
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with reduced birth weight within the normal range and lower risk for being born large-for-
gestational-age [9-11]. Not only does physical activity confer maternal benefits during 
pregnancy, but also the results of earlier research studies have indicated that offspring of 
women who exercised vigorously throughout pregnancy continued to have significantly less 
body fat at five years of age compared to offspring of women who were sedentary during 
pregnancy [40]. Studies in the United States and abroad have found that any improvement in 
glycemic control can benefit individuals at risk for diabetes such that in general, every 
percentage drop in HbA1c blood test results can reduce the risk of microvascular 
complications by 40% [71]. Little is known, however, about how meeting or not meeting the 
current recommendations for physical activity during pregnancy impacts the progression of 
these risk factors for diabetes in non-GDM women.   
Therefore, the purpose of this study is to examine how meeting or not meeting physical 
activity recommendations among a sample of pregnant women ages 19-35 affects the 
progression of diabetes risk status as indicated by both serum and anthropometric markers 
during gestation. It is hypothesized that women participating in more physical activity 
throughout pregnancy will have fewer indications exaggerated above the expected 
pregnancy-related diabetes risk than their less active peers. 
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METHODS 
 
Participant Recruitment 
 
Women who were currently pregnant aged 19-35 living in Harrisonburg-Rockingham 
County and the surrounding areas were recruited for this study. Lead investigators met with 
staff from the Virginia state health department, the Special Supplemental Nutrition Program 
for Women, Infants, and Children (WIC) program, local OBGYN clinics, local private 
birthing and midwifery clinics, yoga studios, and area food banks during the recruitment 
process to promote and explain the study. With approval from all staff involved, information 
pamphlets and flyers about the study were distributed on-site available in both English and 
Spanish.  All interested individuals were asked to contact the Morrison-Bruce Center for the 
Promotion of Physical Activity for Girls and Women (MBC) at James Madison University.  
Informed consent was obtained from every participant per the James Madison University 
Institutional Review Board. 
Testing Procedures 
 
 Once enrolled in the study, women reported to the laboratory for one testing session. 
Gestational duration of pregnancy was recorded during the testing session, and each woman 
was categorized by trimester status. The one hour testing session involved a venous blood 
draw in addition to completing a series of questionnaires and collecting measurements 
including height, weight, hip/waist circumferences, resting blood pressure, and resting heart 
rate. Participants were also given a pedometer and pedometer logbook prior to departure from 
this session and asked to record their daily step counts for two weeks to minimize the 
Hawthorne effect in the first 1-2 days of pedometer usage. All women were shown how to 
operate the pedometer and instructed to wear it in a modified lateral hip location to avoid 
vertical displacement disturbances during pregnancy in the standard mid-thigh-line frontal 
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position. Upon returning the logbook data, women were given the option to either keep the 
pedometer or receive diapers in addition to reading materials with information related to 
physical activity, nutrition, and breastfeeding during pregnancy and postpartum as 
compensation for their voluntary participation in the study. 
Anthropometric Measurements 
Height was measured using a stadiometer to the nearest 0.5 centimeter. Weight was 
measured to the nearest 0.10 kilogram. Modified hip and waist circumference measures were 
collected above and below the fetal growth area and conducted until two measures within 5 
millimeters of each other were recorded. Current waist-to-hip ratio (WHpR) and waist-to-
height ratio (WHtR) for each participant were then calculated using these measures. Resting 
blood pressure and resting heart rate were measured using standardized procedures after each 
participant had been resting in an inclined position for 10 minutes. The same investigator 
collected anthropometric measures for all participants throughout the study.  
Physical Activity Measurements 
Women were asked to complete the Modifiable Activity Questionnaire (MAQ) to 
assess maternal leisure time physical activity (LTPA) [61]. The MAQ has been validated and 
is an acceptable tool for estimating LTPA with women recalling pregnancy related LTPA six 
years postpartum [62]. Participants recalled a typical week of LTPA for the 12-month time 
period prior to the testing session. From a list of forty activities, women selected activities 
that they participated in more than ten times in the past year and reported average durations 
(min/day) and frequencies (day/wk) for each activity.  MET values were assigned to each of 
the chosen activities based on the compendium of physical activities [38]. Volume of LTPA 
was calculated by multiplying the reported frequency and duration by the MET value of each 
activity (MET·min/wk). The American College of Obstetricians and Gynecologists (ACOG) 
recommends that pregnant women participate in at least 150 minutes per week of moderate 
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intensity LTPA [57]. Thus, women were classified as meeting ACOG recommendations if 
their average pregnancy volume of physical activity met or exceeded 450 MET·min/week 
(i.e., the equivalent of 3 METS * 30 min/d * 5 d/wk).  
Total step counts for multiple time periods in addition to weekly averages, weekday 
averages, and weekend averages were calculated from the daily step count data in the 2-week 
pedometer logs for all participants. Women were classified as sedentary (<5000 steps/day), 
low active (5000-7499 steps/day), somewhat active (7500-9999 steps/day), active (≥10000 
steps/day), or highly active (>12500 steps/day) based on their average step counts per day 
during the two week data collection period following the blood draw [65]. All women in any 
of the active categories were then more generally classified as ―active‖ (>5,000 steps/day). 
Biomarker Measurements 
A venous blood sample was obtained after an 8-hour fast via venapuncture of the 
antecubital vein after participants had been seated in a full inclined position for 15 minutes 
[38]. Approximately 29 mL of blood was required in order to analyze the dependent serum 
markers of insulin sensitivity influencing the risk for diabetes including Hemoglobin A1c 
(HbA1c), fasted glucose (BGlu), triglycerides (TGs), high density lipoprotein (HDL), and 
total cholesterol (TCHOL). Two variables (HbA1c and BGlu) were analyzed immediately 
from whole blood.  Plasma was separated from the serum collection tubes after a 30 minute 
incubation period and was centrifuged 20 minutes.  Serum was then frozen in serum tubes at 
-80ºC. After measurement of TCHOL, HDL, and TGs, the Friedewald equation was used to 
predict low density lipoprotein cholesterol (LDLC) values for all subjects calculated as 
TCHOL minus HDL minus (TGs ÷ 5) [66, 67]. 
The American Diabetes Association, the International Diabetes Federation, and the 
European Association for the Study of Diabetes have determined that individuals with 
HbA1c levels between 6.0% and 6.5% should be cautioned that they are in the highest risk 
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group for developing type II diabetes [48]. Insulin resistance is a critical determinant of 
diabetes-related pregnancy risk status among fertile Caucasian and Latina women. Pregnant 
women, for instance, who are not clinically diagnosed with Gestational Diabetes Mellitus 
(GDM) but show serum indications of milder insulin resistance, may still be considered at a 
higher risk during pregnancy for diabetes-related complications and offspring outcomes [32-
35]. Together, these biomarkers can reveal the progressive loss of insulin-secreting function, 
insulin receptor desensitization, and elevated blood glucose associated with type II diabetes 
[32-34].  
Statistical Analysis 
 
 Descriptive statistics were calculated for all independent, dependent, and participant 
variables. Median, range, mean, and standard deviation are reported for all continuous 
variables (i.e. current age, height, weight, WHpR, WHtR, MET·mins/wk, gestational age) 
and frequencies and percentages were computed for all categorical variables (i.e. meeting or 
not meeting ACOG recommendations, step count classifications).  The dependent outcome 
variables in this study were HbA1c, BGlu, HDL, LDL, TCHOL, and TGs. Six scatter plots 
were created to display each woman’s biomarker value on the y-axis in relation to week of 
gestation on the x-axis. Linear regression then constructed the lines of best fit for two groups 
of datapoints depending on whether women were meeting or not meeting physical activity 
recommendations (expressed as both the ACOG recommendation equivalent to 450 
MET·mins/week during pregnancy and ―active‖ step count classification equivalent to >5,000 
steps/day) at the time of the testing appointment. The slopes and intercepts of the two 
regression lines for meeting and not meeting both ACOG and ―active‖ step count 
classification were then compared for differences among each dependent biomarker. The 
correlation between the two measures of physical activity (MAQ and step counts) was also 
examined. Additionally, SPSS version 18.0 was used for univariate (ANCOVA) analysis. 
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The linear regression univariate models between biomarkers and continuous physical activity 
evaluated the significance of physical activity as a predictor of a biomarker value after 
accounting for gestational age as the covariate. A two-tailed alpha level of p < 0.05 indicated 
statistical significance with p<0.1 approaching significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
RESULTS 
 
Characteristics of the participants are shown in Table 11. Of the 23 women who participated in 
the study, 8.7% were in the 1st trimester, 52.2% in 2nd trimester, and 39.1% in 3rd trimester at the time 
of the blood draw and physical activity assessment. Most women were experiencing their first 
pregnancy (70.0%), born in the United States (87.0%), non-Hispanic white (78.3%), residents of 
Rockingham County or the City of Harrisonburg (82.6%), and married or living with a partner 
(87.0%). More than half of the women were middle to high socioeconomic status with 15 (56.5%) 
reporting household income ≥ $50,000/yr. Most participants (87.0%) had an educational training 
beyond high school. 
Table 11: Categorical participant characteristics. 
Characteristics N  % 
Pregnancy Status 
          1st Trimester 
          2nd Trimester 
          3rd Trimester 
 
2 
12 
9 
 
8.7 
52.2 
39.1 
Previous Births 
          None 
          One 
 
14 
6 
 
70.0 
30.0 
Birth Country 
          United States 
          United States—Puerto Rico 
          Botswana, Africa 
          Italy 
 
20 
1 
1 
1 
 
87.0 
4.3 
4.3 
4.3 
Race 
          White (non-Hispanic) 
          Hispanic 
          American Indian/Alaskan Native 
          Asian or Pacific Islander 
 
18 
3 
1 
1 
 
78.3 
4.3 
13.0 
4.3 
Residence 
          Rockingham County 
          City of Harrisonburg 
          Greater Shenandoah Valley 
 
9 
10 
4 
 
39.1 
43.5 
17.4 
Household Income 
          Less than $20,000 
          $20,000-49,999 
          $50,000-79,999 
          $80,000+ 
 
7 
3 
7 
6 
 
30.4 
13.0 
30.4 
26.1 
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Education level 
         NO high school diploma or GED 
         High school degree or GED 
         Two year associate degree 
         Training beyond high school but NO 
degree 
         At least one 4 year college degree  
         At least one graduate degree 
 
1 
2 
3 
3 
7 
7 
 
4.3 
8.7 
13.0 
13.0 
30.4 
30.4 
Marital Status 
          Never married 
          Married or living with partner 
 
3 
20 
 
13.0 
87.0 
 
Descriptive participant characteristics including information about pregnancy, anthropometrics, 
and biomarker risk status are shown in Table 12. At the time of the blood draw, women were 20-33 
years old with a median gestational age of 22 weeks. Pre-pregnancy body mass index (BMI) ranged 
from 19.8 – 36.5 kg/m2 with an average of 26.1kg/m2.  
Recalled physical activity values from questionnaires and pedometer step count data are also 
shown in Table 12. At the time of the blood draw, women participated in moderate or mild physical 
activity an average of 2.5 ± 2.5 or 3 ± 2.4 times in a typical 7 day period respectively, and they spend 
few hours per day sitting at work (mean hours 3.5 ± 2.8). Pedometer step count data shows average 
steps/day in the two-week period following the blood draw to be 4501 ± 1644 steps/day with 
weekdays (4773 ± 1936 steps/day) more active than weekends (3733 ± 1271 steps/day). Pearson 
correlation between MET·mins/wk from the MAQ and average daily step counts from the pedometer 
logs was weak yet significant (r = 0.470, p = 0.042) thus provides statistical support for the 
utilization of either instrument to measure physical activity. 
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Table 12: Descriptive participant characteristics.  
 N Median Range Mean SD 
Pregnancy 
Current Age (yrs) 
Pre-pregnancy weight (kg) 
Pre-pregnancy BMI (kg/m
2
) 
Pregnancy weight gain (lb) 
Weeks gestation 
 
23 
21 
23 
21 
23 
 
27 
61.4 
26.1 
14.6 
22 
 
20-33 
47.3-84.1 
19.8-36.5 
-3.2-35.5 
11-40 
 
26 
61.3 
26.1 
14.6 
23.5 
 
3.7 
10.1 
4.4 
11.3 
8.3 
Anthropometric 
Height (cm) 
Weight (kg) 
Waist-to-Hip Ratio 
Waist-to-Height Ratio 
 
23 
23 
23 
23 
 
161.0 
67.8 
0.85 
0.50 
 
149.4-174.1 
49.4-96.2 
0.77-0.91 
0.41-0.61 
 
161.6 
68.3 
0.85 
0.50 
 
5.9 
12.4 
0.04 
0.05 
Physical Activity 
Days per week* 
          Vigorous 
          Moderate 
          Mild 
Screen hours per day 
Hours sitting at work      
MET·mins/week^ 
          Pre-pregnancy 
          1
st
 Trimester 
          2
nd
 Trimester 
          3
rd
 Trimester 
 
 
Pedometer log step counts 
          Two-week period 
                    Total 
                    Avg/day 
                    Weekday average 
              Weekend average 
 
 
23 
23 
23 
23 
23 
 
23 
23 
18 
6 
 
 
 
 
16 
16 
16 
16 
 
 
0 
2.5 
3 
2.5 
3 
 
1520 
1365 
863 
154 
 
 
 
 
58867 
4205 
4315 
3859 
 
 
0-12 
0-10 
0-8 
1-9 
0-10 
 
0-6590 
0-4388 
0-4288 
0-686 
 
 
 
 
20376-115628 
1455-8259 
1603-9008 
1087-5690 
 
 
1 
2.5 
3 
3 
3.5 
 
2044 
1596 
1294 
259 
 
 
 
 
66156
4501 
4773 
3733 
 
 
2.6 
2.5 
2.4 
2.1 
2.8 
 
1601 
1190 
1322 
309 
 
 
 
 
24281
1644 
1936 
1271 
*Godin Leisure Time Exercise Questionnaire 
^Calculated from the 12-month recall of physical activity on the Modifiable Activity Questionnaire (MAQ) 
 
Table 13 shows the percentage of women meeting or not meeting physical activity 
recommendations based on average MET·mins/week [57] and average step counts/day [65] at the 
time of the blood draw. Prior to becoming pregnant, 20 of the 23 currently pregnant women (87.0%) 
met the ACOG recommendation for physical activity. At the time of the blood draw, 15 (65.2%) of 
the women were meeting ACOG recommendations. Only 4 women (17.4%), however, reported that 
they were currently regularly active (at least 5 days/week, 30 mins/day, at moderate intensity). 
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According to the data from two-week pedometer logs of daily step counts, 12 of the women (75.0%) 
were classified as sedentary (<5,000 avg steps/day) [65]. 
Table 13: Categorical physical activity. 
 N  % 
Meeting ACOG Recommendations (MAQ)
β 
Pre-pregnancy 
1
st
 Trimester 
2
nd
 Trimester 
3
rd
 Trimester 
Average over pregnancy 
Every trimester 
At time of blood draw  
 
20 
19 
11 
2 
17 
16 
15 
 
87.0 
82.6 
61.1 
33.3 
73.9 
69.6 
65.2 
Daily Step Count Recommendations at Blood Draw* 
Sedentary 
Active 
 
12 
4 
 
75.0 
25.0 
Physical Activity 
Currently regularly active^ 
Sweat regularly 
          Rarely/never 
          Sometimes 
          Often 
Average step counts per day* 
          Sedentary 
          Low active 
          Somewhat active 
          Active 
          Highly active 
 
4 
 
9 
13 
1 
 
12 
3 
1 
0 
0 
 
17.4 
 
39.1 
56.5 
4.3 
 
63.1 
26.3 
5.3 
5.3 
0.0 
β 
Calculated from the MAQ, meeting ACOG recommendation 
 >450 MET·mins/week during all stages of pregnancy 
*Sedentary (<5000 steps/day), low active (5000-7499 steps/day), somewhat active (7500-9999 steps/day), active 
(≥10000 steps/day), highly active (>12500 steps/day) 
^From the Health Status Questionnaire, refers to at least 5 days/wk, 30 mins/day, moderate intensity 
**Based on above (high active) or below (low active) the median 1033 MET·mins/week during pregnancy 
 
The results of univariate general linear model (ANCOVA) tests of significance for the two 
factors of gestational age and physical activity level as predictors of biomarker values are shown in 
Table 14. Weeks of gestation was a significant factor in predicting the values of triglycerides 
(p=0.007, p=0.001) and total cholesterol (p=0.039, p=0.013), but meeting ACOG recommendations 
or the ―active‖ step count classification did not present as a significant predictor of any biomarker 
after controlling for gestational age. Recording an ―active‖ daily step count, however, approached 
significance in predicting HbA1c values (p=0.067). 
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Table 14: Univariate general linear model (ANCOVA) test of significance for weeks of gestation and 
physical activity level as predictors of biomarker values. 
 
METmins/week
#
 Step Counts
β
 
Biomarker 
Weeks of 
Gestation 
Meeting 
Recommendations 
Weeks of 
Gestation 
Meeting 
Recommendations 
      Glucose 0.344 0.739 0.515 0.531 
      HbA1c 0.275 0.104 0.223 0.067^ 
      Triglycerides 0.007* 0.864 0.001* 0.635 
      LDL 0.335 0.564 0.232 0.129 
      HDL 0.861 0.790 0.862 0.255 
     Total Cholesterol 0.039* 0.687 0.013* 0.147 
*p<0.05 
^Trend p<0.10 
#
Calculated from MAQ, ACOG recommendation of >450 METmins/wk 
β
Tudor-Locke classifications, ―active‖  >5,000 steps/day 
 
Table 15 summarizes the results of comparing slopes and intercepts between linear regression 
of those meeting and not meeting physical activity recommendations for each dependent biomarker. 
There were significant differences in the slopes for LDL (M0 – M1 = 7.357, p=0.032) and total 
cholesterol (M0 – M1 = 7.568, p=0.043) based on meeting or not meeting an ―active‖ daily step count 
classification. The difference in slopes for HDL based on meeting or not meeting ACOG 
recommendations approached significance (M0 – M1 = 0.947, p=0.051). There were no significant 
differences in the intercepts, however, of any biomarker based on either ACOG or ―active‖ step 
count classification, but meeting or not meeting ACOG recommendations approached significance 
for the HDL biomarker (-22.84, p=0.076). 
Table 15: Comparing slopes and intercepts between linear regression of those meeting1 and not meeting0 
physical activity recommendations for each biomarker of diabetes risk status 
 
METmins/week
#
 Step Counts
β
 
Biomarker 
Difference in 
Intercepts (p) 
Difference in 
Slopes** (p) 
Difference in 
Intercepts (p) 
Difference in 
Slopes** (p) 
      Glucose 7.918 (0.404) -0.35 (0.326) 4.354 (0.637) - 0.298 (0.418) 
      HbA1c -0.677 (0.239) 0.015 (0.477) 0.510 (0.433) - 0.045 (0.152) 
      Triglycerides -10.777 (0.946) 0.763 (0.898) 13.551 (0.939) -1.875 (0.820) 
      LDL -26.724 (0.696) 0.564 (0.825) -112.516 (0.110) 7.357 (0.032)* 
      HDL -22.841 (0.076)^ 0.947 (0.051)^ -5.927 (0.732) 0.587 (0.470) 
      Total Cholesterol -51.721 (0.491) 1.663 (0.552) -115.732 (0.135) 7.568 (0.043)* 
*p<0.05 
^Trend p<0.10 
#
Calculated from MAQ, ACOG recommendation of >450 METmins/wk 
β
Tudor-Locke classifications, ―active‖  >5,000 steps/day 
**M0-M1 
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For visual representation of the results displayed in Table 5, scatter plots and linear 
regression for meeting or not meeting both types of physical activity recommendations are shown for 
BGlu (Figure 1), HbA1c (Figure 2), TGs (Figure 3), LDL (Figure 4), HDL (Figure 5), and TCHOL 
(Figure 6). 
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Fig. (1). Scatter plot and linear regression of glucose values for groups meeting [(A) >450 METmins/wk (B) >5,000 
steps/day] and not meeting physical activity recommendations over gestational weeks during pregnancy. Estimated 
glucose (A) not meeting = 0.378(x) + 61.096,  R
2
 = 0.283 and meeting = 0.027(x) + 69.014, R
2 
 = 0.001 and (B) not 
meeting = 0.133(x) + 65.459,  R
2
 =0.071 and meeting = -0.164(x) + 69.813, R
2 
 = 0.082. The difference in intercepts 
(A) = 7.918, p = 0.404 and (B) = 4.354 , p = 0.637. The difference in slopes (A) = -0.350, p = 0.326 and (B) = -0.298, 
p = 0.418. 
 
 
 
A                                    B   
 
      Not meeting, R2 = 0.283 
   Meeting, R
2 = 0.001 
      Not meeting, R2 = 0.071  
   Meeting, R
2 = 0.082 
Fig. (2). Scatter plot and linear regression of HbA1c values for groups meeting [(A) >450 METmins/wk (B) >5,000 
steps/day] and not meeting physical activity recommendations over gestational weeks during pregnancy. Estimated 
HbA1c (A) not meeting = -0.020(x) + 6.003,  R
2
 = 0.188 and meeting = -0.005(x) + 5.326, R
2 
 = 0.014 and (B) not 
meeting = -0.007(x) + 5.582,  R
2
 = 0.039 and meeting = -0.052(x) + 6.091, R
2 
 = 0.965. The difference in intercepts 
(A) = -0.677, p = 0.239 and (B) = 0.510, p = 0.433. The difference in slopes (A) = 0.015, p = 0.477and (B) = - 0.045, 
p = 0.152. 
 
 
 
A                                    B   
 
      Not meeting, R2 = 0.188 
   Meeting, R
2 = 0.014 
      Not meeting, R2 = 0.039 
   Meeting, R
2 = 0.965 
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Fig. (3). Scatter plot and linear regression of triglycerides values for groups meeting [(A) >450 METmins/wk 
(B) >5,000 steps/day] and not meeting physical activity recommendations over gestational weeks during 
pregnancy. Estimated triglycerides (A) not meeting = 8.177(x) + -23.501,  R
2
 = 0.214 and meeting = 8.940(x) 
+ -34.278, R
2 
 = 0.660 and (B) not meeting = 11.252(x) + -69.835,  R
2
 = 0.599 and meeting = 9.377(x) + -
56.284, R
2 
 = 0.411. The difference in intercepts (A) = -10.777, p = 0.946 and (B) = 13.551, p = 0.939. The 
difference in slopes (A) = 0.763, p = 0.898 and (B) = -1.875, p = 0.820. 
 
 
 A                                    B   
 
      Not meeting, R2 = 0.062 
   Meeting, R
2 = 0.061 
      Not meeting, R2 = 0.031 
   Meeting, R
2 = 0.624 
Fig. (4). Scatter plot and linear regression of LDL values for groups meeting [(A) >450 METmins/wk (B) 
>5,000 steps/day] and not meeting physical activity recommendations over gestational weeks during 
pregnancy. Estimated LDL (A) not meeting = 0.849(x) + 94.881,  R
2
 = 0.062 and meeting = 1.413(x) + 
68.157, R
2 
 = 0.061 and (B) not meeting = 0.535(x) + 79.930,  R
2
 = 0.031 and meeting = 7.892(x) + -32.586, 
R
2 
 = 0.624. The difference in intercepts (A) = -26.724, p = 0.69 and (B) = -112.516, p = 0.110. The 
difference in slopes (A) = 0.564, p = 0.825 and (B) = 7.357, p = 0.032*. 
 
 
 
A                                    B   
 
      Not meeting, R2 = 0.214 
   Meeting, R
2 = 0.660 
      Not meeting, R2 = 0.599 
   Meeting, R
2 = 0.411 
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A                                    B   
 
      Not meeting, R2 = 0.241 
   Meeting, R
2 = 0.262 
      Not meeting, R2 = 0.491 
   Meeting, R
2 = 0.617 
Fig. (6). Scatter plot and linear regression of total cholesterol values for groups meeting [(A) >450 METmins/wk 
(B) >5,000 steps/day] and not meeting physical activity recommendations over gestational weeks during 
pregnancy. Estimated total cholesterol (A) not meeting = 1.964(x) + 167.756,  R
2
 = 0.241 and meeting = 3.628(x) 
+ 116.035, R
2 
 = 0.262 and (B) not meeting = 2.753(x) + 128.044,  R
2
 = 0.491 and meeting = 10.322(x) + 12.312, 
R
2 
 = 0.617. The difference in intercepts (A) =       -51.721, p = 0.491 and (B) = -115.732, p = 0.135. The 
difference in slopes (A) = 1.663, p = 0.552 and (B) = 7.568, p = 0.043*. 
 
 
 
Fig. (5). Scatter plot and linear regression of HDL values for groups meeting [(A) >450 METmins/wk (B) >5,000 
steps/day] and not meeting physical activity recommendations over gestational weeks during pregnancy. 
Estimated HDL (A) not meeting = -0.520(x) + 77.575,  R
2
 = 0.281 and meeting = 0.426(x) + 54.733, R
2 
 = 0.196 
and (B) not meeting = -0.032(x) + 62.081, R
2
 = 0.001 and meeting = 0.555(x) + 56.154, R
2 
 = 0.821. The 
difference in intercepts (A) = -22.841, p = 0.076^ and (B) = -5.927, p = 0.732. The difference in slopes (A) = 
0.947, p = 0.051^ and (B) = 0.587, p = 0.470. 
 
 
 
A                                    B   
 
      Not meeting, R2 = 0.281 
   Meeting, R
2 = 0.196 
      Not meeting, R2 = 0.001 
   Meeting, R
2 = 0.821 
  
 
DISCUSSION 
This study was designed to examine possible relationships between meeting physical 
activity recommendations and biomarkers of diabetes risk status among a sample of pregnant 
women. It was hypothesized that women who were more active at any point in pregnancy 
would show fewer indications of diabetes biomarker risk factors than their less active peers. 
Our results demonstrated significant differences in LDL and TCHOL linear regression slopes 
between women meeting or not meeting an ―active‖ step count classification during 
pregnancy such that women with >5,000 steps/day began pregnancy with lower values of 
these biomarkers at time of gestation and as a classification group, also show a greater 
increase in the slope of linear regression over pregnancy. Additionally, there was a non-
significant trend for a difference in HDL change over the gestational period between women 
meeting and not meeting ACOG recommendations for average MET·mins/week showing an 
increase in HDL for those meeting recommendations. Physical activity levels were not 
significant predictors of any diabetes or lipid biomarker values after controlling for 
gestational age in univariate analysis, yet meeting the ―active‖ step count classification 
approached significance for predicting HbA1c values independent of gestation. Thus, the 
current findings suggest that there may be an influence of physical activity levels on how 
diabetes risk status progresses throughout gestation. 
 To our knowledge, several other studies have examined physical activity levels in 
relation to diabetes risk status over the course of a pregnancy. The linear regression results of 
this study in concert with previously published studies strongly suggest that there is a 
progression toward a metabolically compromising environment during pregnancy [20, 21]. 
During pregnancy, there is an expected shift from lipid deposition to lipid catabolism as 
lipids become the primary maternal energy source while glucose is shunted to the fetus [20, 
68]. Rise in plasma lipid level elevations, however, usually do not exceed 330 mg/dL [22]. In 
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a study by Bessinger et al (2002), exercise during pregnancy caused a reduction in plasma 
glucose levels but elevated circulating triglyceride levels and resting levels of cortisol, 
growth hormone, and insulin. Our study not only supports evidence for these elevated lipid 
levels over the course of gestation, but further adds to the literature suggesting that there may 
be a difference in the progression of biomarkers such as HbA1c, LDL, and TCHOL between 
active and non-active pregnant women.  
 Though only demonstrated as approaching significance, our findings suggest that 
physical activity may also be an independent predictor of HbA1c levels during pregnancy. 
This aligns with the findings of Dempsey et al (2004) and Bessinger et al (2002) showing that 
regular physical activity before and/or during pregnancy is associated with a protective effect 
against developing insulin resistance. Our study adds to this literature by using 
recommendation-based classifications of physical activity levels to reveal any differences in 
the changes of specific risk-related biomarkers for diabetes over a gestational age spectrum. 
The design and results of the current study suggest that although some women may not be 
categorized as ―at risk‖ prior to pregnancy, their risk for diabetes may change in accordance 
with physical activity levels. Not only is it possible that physical activity during pregnancy 
may affect how biomarkers of diabetes risk status increase or decrease with progressing 
gestational age, but several studies have examined this possibility in women without clinical 
diagnosis of diabetes or gestational diabetes mellitus (GDM). It appears that physical activity 
during pregnancy modestly reduces insulin resistance within the normal range and may 
reduce the risk of giving birth to a large infant [17, 33-36].  
In conceptualizing the results of our study, some limitations must be considered. 
Most importantly, the sample consisted of very few women who were inactive prior to 
pregnancy, which could predispose them for entering pregnancy at lower disease risk status 
and likely prevented us from detecting relationships between physical activity levels and 
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progression of risk status. The small, homogeneous sample limited the ability to detect 
relationships based on groupings for activity levels in each trimester, ethnic background, or 
metabolic risk status prior to pregnancy. To definitively address the relationship among of 
trimester status, physical activity, ethnicity, and risk factors for diabetes, future studies could 
be conducted that include a larger sample size with an even distribution of participants across 
trimesters and ethnic diversity.  Unfortunately, our study could not employ this statistical 
analysis procedure of comparing biomarker means between women meeting or not meeting 
physical activity recommendations in each trimester due to small sample sizes in sub-
groupings. Additionally, physical activity in our study was measured using both a recall and 
applied methodology facilitating two mutually exclusive perspectives of physical activity 
during a ―snapshot‖ period of pregnancy. Despite these differences, our results are similar to 
related studies, suggesting that physical activity may have an influence on the natural 
progression of fasted blood glucose, glycosylated hemoglobin, and lipid biomarkers involved 
in insulin resistance and diabetes risk status during pregnancy [9, 20-22, 38, 69]. However, 
these are still preliminary findings that require further data collection testing these 
relationships in larger, more diverse cohorts of women in each stage of pregnancy. Despite 
the limited data our study provides some evidence through scatter plot and visual depiction of 
linear regression that examining the biomarker changes at different stages in pregnancy may 
be worth pursuing because the degree of change in risk factors associated with diabetes may 
be impacted by volume of physical activity.  
The methodology for assessing physical activity habits in our study was heavily 
dependent on recalled information on maternal physical activity during pregnancy. We used 
the Modifiable Activity Questionnaire, which has been previously validated for use recalling 
pregnancy-related physical activity at six years post partum [62]. Recall length in this study 
was much shorter which strengthens confidence in the reported physical activity levels. Yet, 
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while the self-report data is valid, it may not provide the same accuracy as objective 
measures such as using accelerometers or metabolic devices over an extended measurement 
period. Thus, the self-report data in this study is supplemented by an additional measure of 
current physical activity from pedometers and two-week log books which further provides an 
avenue for directly measuring current activity volume. The correlation between these two 
measures was weak yet significant. This is important for additional studies involving 
pregnant women and pedometers in the future if investigators want to follow women 
throughout pregnancy because the pedometer is an inexpensive way to measure activity and 
avoid ―questionnaire fatigue‖. If subjects are given the appropriate cues, a step rate per 
minute can be determined which could further provide some intensity data and supplement 
self-reported information about physical activity levels. Despite the overall limitations in this 
study, these results provide preliminary support that physical activity during pregnancy may 
impact the progression of diabetes risk factors throughout gestation. While the external 
validity of this study is hindered by the small sample size and subsequent grouping 
capabilities, internal validity is strong. A single trained investigator directly obtained all 
anthropometric measurements, and blood draw protocol was consistent for all participants. 
This study’s statistical procedures and methodology have been designed to accommodate a 
larger sample size in the future to enhance the capability to examine relationships. 
In conclusion, these results partially supported the original hypothesis that there would be 
a relationship between physical activity levels and biomarkers of diabetes risk status. There 
were significant differences in LDL and total cholesterol linear regression slopes between 
women meeting or not meeting step count recommendations such that women meeting 
recommendations had greater increases in these biomarkers over pregnancy. This suggests 
that there may be an interaction between physical activity levels and the lipid profile over the 
course of gestation. Additionally, there was a non-significant trend for greater increases in 
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HDL among women meeting ACOG recommendations for physical activity during 
pregnancy. Physical activity levels were not significant predictors of any biomarker values 
after controlling for gestational age, yet meeting step count recommendations showed a trend 
toward significance for predicting HbA1c values independent of gestation. The current 
ACOG recommendations for physical activity during pregnancy are promoted based on 
interest in maximizing maternal benefits and reducing risk for chronic diseases [9, 57]. These 
results further suggest that physical activity during pregnancy may influence how risk status 
changes throughout gestation as well as the risk status upon entering pregnancy. 
Unfortunately, women are commonly encouraged to abstain from activity during pregnancy. 
Population-based data indicate that very few women (16%) meet ACOG recommendations 
[70]. Physicians and allied health practitioners may not be providing patients with the 
knowledge or contemporary guidelines based on evidenced-based research encouraging 
physical activity during pregnancy. Knowledge of any potential attenuation to the risks of 
chronic disease development during pregnancy, however, may encourage women to be more 
active during pregnancy while also fueling public health education efforts aimed at increasing 
knowledge among maternal and child health practitioners. Further study in larger, more 
diverse populations is needed to investigate the relationships between physical activity and 
biomarkers of disease, while considering ethnic-based comparisons and other pre-disposing 
risk factors or behaviors. 
 
 
 
  
 
Chapter V 
Summary 
Elevated insulin resistance during pregnancy is a significant health concern due to the 
increased risk for diabetes and other chronic diseases and conditions for both mother and 
child [13-16]. Specifically, offspring born to mothers with diabetic gestation not only suffer 
from increased risk of infant morbidity and obesity, but gestational exposure to glucose 
intolerance is also strongly linked to the future development of type II diabetes in the 
offspring [12, 17-19]. Pregnancy is a physiological state that already compromises maternal 
insulin sensitivity as a normal manner of supplying adequate fuel sources to the growing 
fetus [20]. Early pregnancy favors lipid deposition in the mother while inhibiting lipolysis as 
placenta hormones such as estrogen and progesterone aid fetal growth but block the action of 
the mother’s insulin [21]. Mobilization of lipid stores in late pregnancy occurs as a shift from 
an anabolic to a catabolic state promotes the use of lipids as a maternal energy source while 
preserving glucose to the fetus [20]. Thus, insulin action in late normal pregnancy mimics a 
diabetic environment [20]. This progression of insulin resistance during pregnancy can 
become an issue of concern, however, if other metabolically-threatening factors are present 
causing elevations above the expected adaptations [23-25]. 
For certain populations of ethnic women, compromised insulin sensitivity begins 
early in life [44]. Latina women, for example, are more likely than their non-Latina peers to 
be diagnosed with clinical insulin resistance during pregnancy [1, 27].  Hormonal changes 
during puberty already induce more intense development of insulin resistance in this 
population [32]. Therefore, women in high-risk populations enter child-bearing years with a 
compromised state of insulin sensitivity [32]. Insulin resistance is an indicator of pregnancy 
risk status, and pregnant women who are not clinically diagnosed with GDM but show 
biomarkers of milder insulin resistance, may still be considered at a higher risk during 
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pregnancy for diabetes-related complications and offspring outcomes [33-36]. Elevated 
plasma lipid profiles, large waist circumferences and anthropometric ratios, and chronically 
high glycosylated hemoglobin (HbA1c) percentages can reveal chronically elevated blood 
glucose levels that are associated with type II diabetes [33-35].  
As a potential avenue in attenuating both biochemical and anthropometric risk status, 
participation in regular physical activity may help an individual reduce excess body fat and 
improve overall body composition [37]. Moreover, regular physical activity is known to 
positively impact precursors for diabetes, and any improvement can then benefit an 
individual at risk for diabetes[23, 38, 39]. Less is known, however, about how meeting 
physical activity recommendations over the spectrum of a gestational period impacts the rate 
of change in biomarkers of chronic disease risk.  The purpose of this study was to determine 
if meeting physical activity recommendations among a sample of pregnant women ages 19-
35 was related to diabetes risk status as indicated by fasted blood glucose (BGlu), 
glycosylated hemoglobin (HbA1c), total cholesterol (TCHOL), low density lipoprotein 
cholesterol (LDLC), high density lipoprotein cholesterol (HDLC) and triglycerides (TGs). It 
was hypothesized that women participating in more physical activity throughout pregnancy 
would have fewer indications exaggerated above the expected pregnancy-related diabetes risk 
than their less active peers. 
Women who were currently pregnant aged 19-35 living in Harrisonburg-Rockingham 
County and the surrounding areas were recruited for this study. Women who met the study 
criteria reported to the laboratory for a testing session involving a venous blood draw, 
completing a series of questionnaires, and collecting anthropometric measurements. 
Participants received a pedometer and pedometer logbook prior to departure from this session 
and recorded their daily step counts for two weeks. The Modifiable Activity Questionnaire 
(MAQ) assessed maternal leisure time physical activity (LTPA) through recalling activity 
63 
 
 
 
participation in the past year and reporting average durations (min/day) and frequencies 
(day/wk) for each activity [62].  Women were then classified as meeting ACOG 
recommendations if their average pregnancy volume of physical activity met or exceeded 450 
MET·min/week (i.e., the equivalent of 3 METS * 30 min/d * 5 d/wk). Women were also 
classified as ―active‖ (>5000 steps/day) based on their average step counts per day from the 
two-week pedometer logs [65]. Dependent biomarkers of insulin sensitivity influencing the 
risk for diabetes included fasted blood glucose (BGlu), glycosylated hemoglobin (HbA1c), 
total cholesterol (TCHOL), low density lipoprotein cholesterol (LDLC), high density 
lipoprotein cholesterol (HDLC) and triglycerides (TGs). Scatter plots were created to display 
each woman’s biomarker value in relation to week of gestation, and linear regression 
constructed lines of best fit for two groups of data points depending on whether women were 
meeting or not meeting physical activity recommendations at the time of the testing 
appointment. The slopes and intercepts of the two regression lines were compared for 
differences among each of the six dependent biomarkers. Additionally, linear regression 
between biomarkers and physical activity evaluated the significance of physical activity as a 
predictor of a biomarker value after accounting for gestational age.  
This study aimed to examine how meeting or not meeting physical activity 
recommendations among a sample of pregnant women affects biomarkers of diabetes risk 
status. It was hypothesized that women who were more active at any point in pregnancy 
would show fewer indications of diabetes biomarker risk factors than their less active peers. 
Of the 23 women who participated in the study, 8.7% were in the 1st trimester, 52.2% in the 
2nd trimester, and 39.1% in the 3rd trimester at the time of the blood draw. Also at time of 
blood draw, 15 (65.2%) of the women were meeting ACOG recommendations and 4 (25.0%) 
were classified by step counts as ―active‖ from their two-week pedometer log data following 
the lab visit. Results demonstrated significant differences in LDL and total cholesterol linear 
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regression slopes between women above and below the ―active‖ step count classification 
such that women with >5,000 steps/day began pregnancy with lower values at time of 
gestation, and the regression slope had a greater increase over pregnancy. Additionally, there 
difference approaching significance in HDL change over the gestational period between 
women meeting and not meeting ACOG recommendations showing an increase in HDL for 
those meeting recommendations. Physical activity levels were not significant predictors of 
any biomarker values after controlling for gestational age, yet an ―active‖ step count 
classification approached significance for predicting HbA1c values independent of gestation.  
During pregnancy, there is an expected shift from lipid deposition to lipid catabolism as 
lipids become the primary maternal energy source while glucose is shunted to the fetus [20, 
68]. In a study by Bessinger et al (2002), exercise during pregnancy caused a reduction in 
plasma glucose levels but elevated circulating triglyceride levels and resting levels of 
cortisol, growth hormone, and insulin. This study provides some evidence for elevated lipid 
levels in pregnant women however, because the participants were not followed throughout 
their pregnancy it is difficult to determine the role that physical activity may play in 
moderating lipid levels.   In contrast to the lipid data, our findings suggest that physical 
activity may be an independent predictor of glucose regulation during pregnancy similar to 
Dempsey et al (2004) and Bessinger et al (2002) showing how regular physical activity 
before and/or during pregnancy is associated with a protective effect against developing 
insulin resistance. Using recommendation-based groupings of physical activity levels to 
reveal changes of risk-related biomarkers of insulin resistance over a gestational age 
spectrum adds to current literature. Unlike previous studies on this topic, assessing physical 
activity with scatter plot and linear regression analysis based on meeting or not meeting 
physical activity recommendations allows for examining changes in biomarkers over 
pregnancy among women not clinically presenting diabetes risk status. In the future, further 
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data collection can be done to help determine if meeting current physical activity 
recommendations provides a high enough dose of benefits to facilitate any diabetes risk 
reduction. 
These are still preliminary findings, and larger studies with prospective measurements of 
physical activity during pregnancy are needed to examine the consistency in these 
relationships as well as detect any other differences in changes over gestation among the 
factors related specifically to insulin resistance and diabetes risk status. The sample consisted 
of very few women who were inactive prior to pregnancy, and homogeneity in demographics 
limited the ability to detect relationships based on groupings for activity levels in each 
trimester or ethnic background. Future studies should utilize trimester-specific biomarker 
values and physical activity level data from a larger, diverse sample of women to compare 
means. Despite the limitations, these results provide preliminary support that physical 
activity during pregnancy may impact the progression of biomarkers for diabetes risk factors 
throughout gestation. This study’s statistical procedures and methodology have been 
designed to accommodate a larger sample size in the future to enhance the capability to 
examine relationships. Knowledge of risk reduction during and after pregnancy may 
encourage women to be more active during pregnancy and fuel health education efforts 
among maternal and child health practitioners. 
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Appendices 
Appendix I: Consent for Investigative Procedure  
Consent to Participate in Research 
 
Identification of Investigators & Purpose of Study   
You are being asked to participate in the Fit-Minded Mamas (Madres Saludables) research study 
conducted by Dr. Judith A. Flohr, Kelly Mattran, and Christine Nicewonger from James Madison 
University.  The purpose of this study is to look at how volume of physical activity during 
pregnancy and/or right after child birth changes is related to blood sugar and the blood’s ability to 
form and break down blood clots.  This information is important because it helps us provide 
researchers with information on factors that increase or decrease an individual’s risk for diabetes 
and/or heart disease. This study will contribute to the researchers’ completion of their master’s 
theses. 
 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this consent 
form once all your questions have been answered to your approval.  This study consists of ONE 
testing session and the completion of a 2-week pedometer log. The testing session involves filling 
out forms related to physical activity and your feelings toward physical activity; measurements 
including height, weight, hip/waist circumferences, and blood pressure; and a blood draw. The 
blood will be tested for the factors/chemicals that help control blood sugar levels and influence 
your risk for diabetes (the chemicals/factors are blood lipids, hemoglobin A1c (HbA1c), fasted 
insulin, fasted glucose) and factors that control how quickly your blood clots (the factors are, tPA 
activity, tPA antigen, PAI-1, von Willebrand factor, and fibrinogen).  The 2-week pedometer log 
is a form where you will record the number of steps you take each day, measured by a small 
device called a pedometer, which will be provided.   
 
Time Required 
Participation in this study will require a total of approximately 90 minutes of your time. The test 
session may take up to an hour of your time.  Filling out the pedometer logs and turning them in 
is intended to take less than 30 minutes (spread out over the two week measurement period). We 
may also contact you, via phone, following this study, to ask you questions about your study 
experience.   
 
Risks  
The investigators do not see more than minimal risks from your involvement in this study.  
Trained phlebotomists from the JMU Department of Kinesiology and/or JMU Health Center will 
be utilized for all blood draws in which ~3 Tablespoons of blood will be taken.  The blood draws 
are of no greater risk than any other blood draw which would normally occur during pregnancy. 
Safety procedures will be followed during the blood draw, including that the researchers will 
wear non-latex gloves.  After use, sharp objects will be placed in a sharps biohazard container and 
any other biohazard material will go in a biohazard bag to be discarded at Rockingham Memorial 
Hospital.  Following each blood draw, the area where your blood draw was taken will be cleaned 
and bandaged.   
 
Benefits 
Potential benefits from participation in this study include obtaining all blood work results. In 
addition, participants will be provided with a pedometer (a device that counts the number of steps 
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you take). Participants will also receive pregnancy-related reading materials to keep after the 2-
week pedometer log is completed and returned to us.     
 
Confidentiality  
The results of this research will be presented at Masters’ thesis defenses.  The results of this 
project will be coded in such a way that the respondent’s identity will not be attached to the final 
form of this study.  The researcher retains the right to use and publish non-identifiable data.  
While individual responses are confidential, aggregate data will be presented representing 
averages or generalizations about the responses as a whole.  All data will be stored in locked file 
cabinets accessible only to the researchers.  Personal information will be stored separately from 
files with data items, and identification numbers will replace participant names on all 
questionnaires in which signatures are not required. Upon completion of the study, all 
information that matches up individual respondents with their answers will be destroyed.  
 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind. 
 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or after its 
completion or you would like to receive a copy of the final aggregate results of this study, please 
contact: 
Kelly Mattran   Christine Nicewonger   Dr. Judith A. Flohr 
  
Department of Kinesiology Department of Kinesiology  Department of 
Kinesiology  
James Madison University James Madison University  James Madison 
University 
540-568-4348   540-568-4348    540-568-3448 
mattraka@dukes.jmu.edu nicewocm@ad.jmu.edu  flohrja@ad.jmu.edu  
 
Questions about Your Rights as a Research Subject 
Dr. David Cockley  
Chair, Institutional Review Board 
James Madison University 
(540) 568-2834 
cocklede@jmu.edu 
 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form.  I certify that I am at least 18 
years of age. 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
 
______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
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Appendix II: Health Status Questionnaire  
Health History Questionnaire 
Instructions: Complete each question accurately. All information provided is 
confidential. 
Part I:  Demographic Information 
 
1.         2.      
 Subject ID  Number      Date 
           
3.           
 Local Phone 
 
4. Email: ____________________________________ 
 
5. Sex (circle one)  Male   Female 
 
6. Date of Birth       
    Month/ Day/ Year 
Part II: Medical History 
 
7. Circle any that died of heart attack before age 50:  Father  Mother  Brother  Sister  
Grandparent  
8. Date of last medical exam: _____________ Last physical fitness test: _________ 
 
9. Circle operations you have had:  Back   Heart   Kidney   Eyes    Joint    Neck     Ears     
Hernia   Lung     Other ________________ 
 
10. Please circle any of the following for which you have been diagnosed of treated by a 
physician or health professional: 
 
Alcoholism   Diabetes   Kidney Problems 
Anemia (sickle cell)  Emphysema   Mental Illness 
Anemia (other)  Epilepsy   Muscular Injury 
Asthma   Eye Problems   Neck Strain 
Back Strain   Gout    Obesity 
Bleeding trait   Hearing Loss   Orthopedic Injuries 
Bronchitis, chronic   Heart Problem   Phlebitis 
Cancer    High Blood Pressure  Rheumatoid arthritis 
Cirrhosis, liver  Hypoglycemia   Stroke 
Concussion   Hyperglycemia  Thyroid problem 
Congenital defect  Infectious Mononucleosis Ulcer 
Other _____________________ 
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11. Circle all medications taken in the last six months: 
 
Blood thinner   Epilepsy medication  Nitroglycerin 
Diabetic pill   Heart-rhythm medication Other __________________ 
Digitalis   High-blood pressure medication 
Diuretic   Insulin 
ID # ______________________ Date ___________________________ 
 
12. Any of these health symptoms that occur frequently is the basis for medical attention. 
Circle the number indicating how often you have each of the following: 
 
5 = Very often    4 = Fairly often   3 = Sometimes   2 = Infrequently   1= Practically never 
 
a. cough up blood   f. chest pain 
    1   2   3   4   5      1   2   3   4   5 
 
b. abdominal pain   g. swollen joints 
    1   2   3   4   5                    1   2   3   4   5 
 
c. low back pain   h. feel faint 
    1   2   3   4   5       1   2   3   4   5 
 
d. leg pain    i. dizziness 
    1   2   3   4   5       1   2   3   4   5 
 
e. arm or shoulder pain  j. breathless on slight exertion 
    1   2   3   4   5        1   2   3   4   5 
 
Part III: Health Related Behavior 
13. Do you smoke?  Yes No 
 
14. If you are a smoker, indicate the number smoked per day: 
 
Cigarettes:  40 or more  20-39  10-19  1-9 
 
Cigars or pipes only:  5 or more or any inhaled less than 5, none inhaled 
 
15. Do you exercise regularly? Yes No 
 
16. How many times in a week do you spend at least 30 minutes in moderate to 
strenuous/vigorous exercise? 
 
 1 2 3 4 5 6 7 days per week 
 
17. Can you walk 4 miles briskly without fatigue? Yes No 
 
18. Can you jog 3 miles continuously at a moderate pace without discomfort?  Yes      No
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Appendix III: Modifiable Activity Questionnaire  
MODIFIABLE ACTIVITY QUESTIONNAIRE ID# _____________ Date _____________ 
1. Please check the box of all activities that you have done more than 10 times in the last 12 months 
from ____________________ to ____________________. 
Activity Month Frequency Duration 
 
JA
N
 
F
E
B
 
M
A
R
 
A
P
R
 
M
A
Y
 
JU
N
 
JU
L
 
A
U
G
 
S
E
P
 
O
C
T
 
N
O
V
 
D
E
C
 Average # 
of times 
per month 
Average 
# of 
minutes 
each time 
 Aerobic Dance/Step Aerobics               
 Badminton               
 Basketball               
 Bicycling (indoor, outdoor)               
 Bowling               
 Calisthenics/Toning Exercises               
 Canoeing/Rowing/Kayaking               
 Dancing (square, line, ballroom)               
 Elliptical Trainer               
 Fencing               
 Fishing               
 Football/Soccer               
 Gardening or Yardwork               
 Golf               
 Hiking               
 Horseback Riding               
 Hunting               
 Jogging (outdoor, indoor)               
 Jumping Rope               
 Martial Arts (karate, judo)               
 Pilates               
 Raquetball/Handball/Squash               
 Rock Climbing               
 Scuba Diving               
 Skating (roller, ice, blading)               
 Snow Shoeing               
 Snow Skiing (downhill)               
 Snow Skiing (x-country, Nordic   
Track) 
              
 Softball/Baseball               
 Stairmaster               
 Strength/Weight Training               
 Swimming (laps, snorkeling)               
 Tai Chi               
 Tennis               
 Volleyball               
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 Walking for Exercise (outdoor, 
indoor, treadmill) 
              
 Water Aerobics               
 Yoga               
 Other _____________________               
 
2. Excluding time at work, in general how many HOURS per DAY do you usually spend 
watching television or working on the computer? ________ hours 
 
3. Over this past year, have you spent more than one week confined to a bed or chair as a 
result of an injury, illness, or surgery? Yes _______  No _______ 
 If yes, how many weeks over the past year were you confined to a  
bed or chair? _______ weeks. 
 
4. Do you have difficulty doing any of the following activities? 
 a. getting in or out of a bed or chair?   Yes _______  No _______ 
 b. walking across a small room without resting? Yes _______  No _______ 
c. walking for 10 minutes without resting?  Yes _______  No _______    
5. Did you ever compete in an individual or team sport (not including any time spent in sports 
performed during school physical education classes)? Yes _______  No _______ 
 If yes, how many total years did you participate in competitive sports? _______ years 
 
6. Have you had a job for more than one month over the past year, from last _____ to 
this_____? 
 
List all JOBS that the individual held over the past 12 months for more than one month.        
Account for all 12 months of the past year.  IF unemployed/disabled/homemaker/student during 
all or part of the past 12 months, list as such and probe for job activities of a normal 8 hour day, 
5 day week. 
 
 
 
 
 
 
 
 
 
Job 
Name 
 
 
 
 
 
 
 
 
Job 
Code 
 
 
Walk or 
bicycle 
to/from 
work 
 
 
 
Min/Day 
Average Job Schedule 
 Out of the total # of ―hrs/day‖ the individual 
reported working at this ―job‖, how much of 
this time was usually spent sitting?  Enter this # 
in ―hrs sitting‖ column, then place a check in 
the category that best describes their job 
activities when they are not sitting.  
Hrs. 
spent 
sitting at 
work 
Check the category that best 
describes job activities when 
not sitting 
 
 
 
 
 
Mos/Yr 
 
 
 
 
Days/Wk 
 
 
 
 
Hrs/Day 
 
 
 
Hrs 
Sitting 
 
 
 
 
A 
 
 
 
 
B 
 
 
 
 
C 
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Appendix IV: Godin Leisure Time Exercise Questionnaire  
Study ID _______________________ Date __________________________ 
Godin Leisure-Time Exercise Questionnaire 
 
1. During a typical 7-Day period (a week), how many times on the average do you do the following kinds 
of exercise for more than 15 minutes during your free time (write on each line the appropriate 
number). 
  Times Per 
Week   
a) STRENUOUS EXERCISE 
 (HEART BEATS RAPIDLY) __________ 
 (e.g., running, jogging, hockey, football, soccer, 
 squash, basketball, cross country skiing, judo, 
 roller skating, vigorous swimming, 
  vigorous long distance bicycling) 
b) MODERATE EXERCISE 
 (NOT EXHAUSTING) __________ 
 (e.g., fast walking, baseball, tennis, easy bicycling, 
 volleyball, badminton, easy swimming, alpine skiing, 
 popular and folk dancing) 
c) MILD EXERCISE 
 (MINIMAL EFFORT) __________ 
 (e.g., yoga, archery, fishing from river bank, bowling, 
 horseshoes, golf, snow-mobiling, easy walking) 
 
2. During a typical 7-Day period (a week), in your leisure time, how often do you engage in 
any regular activity long enough to work up a sweat (heart beats rapidly)? 
 
 OFTEN  SOMETIMES  NEVER/RARELY 
 
 
 
 
 
 
 
Godin, G., & Shephard, R.J. (1985). A simple method to assess exercise behavior in the 
community. Can J Appl Sport Sci,   10 , 141-146. 
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Appendix V: Physical Activity Stages of Change Questionnaire  
ID # _____________________   Date _________________________ 
 
Physical Activity Stages of Change 
For each of the following questions, please circle Yes or No.  Please be sure to read the 
questions carefully. Physical activity or exercise includes activities such as walking 
briskly, jogging, bicycling, swimming, or any other activity in which the exertion is at 
least as intense as these activities. 
 
           NO
 YES 
 
1. I am currently physically active.                                                                     0           
1 
 
2. I intend to become more physically active in the next 6 months.  0   
1  
 
 
For activity to be regular, it must add up to a total of 30 minutes or more per day and be 
done at least 5 days per week.  For example, you could take one 30-minute walk or take 
three 10-minute walks for a daily total of 30 minutes. 
 
           NO
 YES 
 
3. I currently engage in regular physical activity.    0
 1 
  
4. I have been regularly physically active for the past 6 months.  0
 1  
 
 
 
 
 
 
 
 
 
74 
 
 
 
Appendix VI: Exercise Self Efficacy Questionnaire  
ID # _________________________ Date _________________________ 
 
Exercise Self Efficacy 
The items listed below are designed to assess your beliefs in your ability to continue participation in 
physical activity on a five time per week basis at moderate intensities (upper end of your perceived exertion 
range), for at least 30+ minutes per session in the future.  Using the scales listed below please indicate how 
confident you are that you will be able to continue to exercise in the future. 
 
For example, if you have complete confidence that you could be physically active five times per week at 
moderate intensity for 30+ minutes for the next four weeks without quitting, you would circle 100%.  
However, if you had no confidence at all that you could be physically active five times per week at a 
moderate intensity for 30+ minutes for the next four weeks without quitting, (that is, confident you would 
not be active), you would circle 0%. 
 
Please remember to answer honestly and accurately.  There are no right or wrong answers. 
Mark your answer by circling a %: 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
NOT AT ALL       MODERATELY               HIGHLY 
CONFIDENT          CONFIDENT           
CONFIDENT 
 
 
1.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT WEEK 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
 
2.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT TWO WEEKS 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
 
3.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT THREE WEEKS 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
 
4.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT FOUR WEEKS  
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
 
5.  I am able to continue to participate in physical activity at least five times per week at moderate 
intensity, for  30+ minutes without quitting for the NEXT FIVE WEEKS 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
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6.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT SIX WEEKS 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
Mark your answer by circling a %: 
 
7.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT SEVEN WEEKS 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
 
8.  I am able to continue to participate in physical activity at least five times per week at moderate intensity, 
for  30+ minutes without quitting for the NEXT EIGHT WEEKS 
 
0% 10%  20%  30%  40%  50%  60%  70%  80%  90%  100% 
  
 
Modified for Fit Minded from: McAuley, E. (1993). Self-efficacy and the maintenance of exercise 
participation in older adults. Journal of Behavioral Medicine, 16, 103-113. 
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Appendix VII: Participant Characteristics Questionnaire 
Fit-Minded Mamas: Supplemental Participant Characteristics 
 
If you are CURRENTLY PREGNANT: 
How far along are you in your current pregnancy? _______wks 
___1st Trimester 
___2nd Trimester 
___3rd Trimester 
When are you due? __________________(m/d/y) 
 
If you are NOT CURRENTLY PREGNANT (postpartum): 
How old is your most recent child? _______months 
How old were you when you last gave birth? ______yrs 
How much weight did you gain while you were pregnant? 
_______________lbs 
How much did you weigh before you became pregnant? _____________lbs 
Have you had previous births? ___yes ___no 
a. If yes, how many? _________ 
 
1. What country were you born in?  _________________ 
2. What is your race/ethnicity? (check all that apply) 
___ White (non-Hispanic) 
___ Black (non-Hispanic) 
___ Am Indian/Alaskan Native 
___ Hispanic 
___ Asian or Pacific Islander 
___Other: ___________________ 
3. Which of the following best describes where you live? (Please check one) 
___City of Harrisonburg    
___Rockingham County 
4. Do you feel like there are safe and easily accessible walking routes to and from your house? 
___Yes ___No 
5. Which of the following best describes your current work status? (Please check one) 
___ I am NOT employed outside the home 
___ I am employed part time (less than 35 hours a week) 
___ I am employed fulltime outside the home (35 hours or more a week) 
___ I operate a home based business 
6. Which of the following best describes your average household income? (Please check one) 
___ < $20,000      ___ $20,000-49,999 
___ $50,000-79,999 ___ $80,000+ 
7. Which of the following best describes your highest educational status? (Please check one) 
___ I have NOT received a high school diploma or a GED. 
___ I have a high school degree or a GED 
___ I have a two-year associate degree. 
___ I have education training beyond high school, but I DO NOT have a college 
degree. 
___ I have received at least one, four-year college degree (ie. Bachelors degree) 
___I have received at least one graduate degree (ie. Masters degree, PhD, MD, etc.) 
8. Which of the following best describes your current marital status? (Please check one) 
___ Never married   ___Widowed 
___Divorced/separated   ___ Married or living with partner 
EVERYONE ANSWER 
THESE QUESTIONS 
Please fill in 
ONE of 
these two 
boxes 
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Appendix VIII: Pre-Blood Draw Questionnaire 
ID # __________________________ Date _______________________________ 
 
Questionnaire for Blood Draws 
 
 
1. Have you consumed alcoholic beverages within the last 24 hours? ________________ 
 
 
2. Have you used nicotine within the last 10 hours? __________________ 
 
 
3. Have you consumed any food or drink, except water, within the last 10 hours? ______ 
 
 
4. Have you had any infection, fever, or illness within the last week? ________________ 
 
 
5. Have you taken any medication, vitamins, or other nutritional/herbal supplements  
    within the last 12 hours? ______________________________________________ 
 
 
If yes to any question, please explain: 
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Appendix IX: Exercise Benefits to Barriers Questionnaire 
Exercise Benefits to Barriers Ratio Scale 
 
Perceptions About Exercise and Physical Activity  
Please read the following statements regarding your personal beliefs toward regular 
exercise.  For each question, circle the ONE answer that best corresponds to how you feel.  
Each statement allows you to select one of the following responses: strongly agree, agree, 
disagree, or strongly disagree. 
 
 strongly 
agree 
agree disagree strongly 
disagree 
1) Exercise improves disposition     
2) Places to exercise are too far away     
3) Exercise helps you sleep better     
4) I am too embarrassed to exercise     
5) Exercise decreases fatigue     
6) It costs too much to exercise     
7) Exercise improves self-concept     
8) Most facility schedules are inconvenient     
9) Exercise increases mental alertness     
10) People in exercise clothes look funny     
11) Exercise helps you carry out normal 
activities without tiredness 
    
12) There are too few places to exercise     
13) Exercise improves quality of work     
14) Exercise takes too much time away 
from family responsibilities 
    
15) Exercise improves overall body 
functioning 
    
16) Exercise increases muscular strength     
17) Exercise takes too much of my time     
18) Exercise makes your physical fitness 
level higher 
    
19) Exercise is tiring     
20) Exercise improves muscle tone     
21) Exercise is fatiguing     
22) Exercise increases cardiovascular 
functioning 
    
23) Exercise is hard work     
24) Exercise increases stamina     
25) Exercise improves flexibility     
26) My partner/spouse does not encourage 
me to exercise 
 
    
27) My family does not encourage me to 
exercise 
    
28) Exercise improves physical endurance     
29) Exercise improves the way my body 
looks 
    
30) I enjoy exercise     
31) Exercise relieves stress and tension     
32) Exercise improves mental / emotional     
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health 
33) Exercise gives me a sense of personal 
accomplishment 
    
34) Exercise helps me feel relaxed     
35) Exercise improves my feeling of well-
being 
    
36) Exercise helps me to have contact with 
my friends 
    
37) Exercise helps me to meet people     
38) Exercise is good entertainment     
39) Acceptance by others is increased by 
exercising 
    
40) Exercise prevents heart attacks     
41) Exercise prevents high blood pressure     
42) Exercise helps people live longer     
43) Exercise is hard because my health is 
poor 
    
44) Exercise is hard because I am not 
motivated to exercise 
    
45) I don’t exercise because I fear for my 
safety 
    
46) I don’t exercise because there are no 
activities appropriate for my culture 
    
47) I don’t exercise because I am not 
interested in any activities offered 
    
48) I don’t exercise because I don’t know 
much about the proper way to exercise 
    
49) I don’t exercise because I feel old     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE: Sechrist, K.R., Walker, S.N., & Pender, N.J. (1987).  Development and psychometric 
evaluation of the Exercise Benefits / Barriers Scale.  Research in Nursing & Health, 10, 357-365. 
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Appendix X: Pedometer Log Book 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WEEK 1 PEDOMETER DIARY 
WEEK OF: 
Weekend Average 
(steps): 
Weekday Average 
(steps): 
Weekly Total (steps): 
            Other 
Activities: 
Day of the Week: Total Daily Step 
Count: 
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